Fifth Universal Definition of Myocardial Infarction (2026)
By: Nicholas L. Mills, L. Kristin Newby, Sarah Zaman, Wael A. Almahmeed, Chiara Bucciarelli-Ducci, Monica M. Colvin, George D. Dangas, Holli A. DeVon, Rohan Dharmakumar, Thomas A. Gaziano, Derek J. Hausenloy, Mohamed Jeilan, Konstantinos C. Koskinas, Bertil Lindahl, Zuzana Motovska, Maria Rubini Gimenez, Ana María Salvati, Jacqueline E. Tamis-Holland and ESC/ACC/AHA/WHF Universal Definition Document Advisory Group
References
- Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, et al. 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2023;44:3720–3826. DOI: 10.1093/eurheartj/ehad191
- Rao SV, O’Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, et al. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2025;151:e771–e862. DOI: 10.1161/CIR.0000000000001309
- Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45:3415–3537. DOI: 10.1093/eurheartj/ehae177
- Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation. 1979;59:607–609. DOI: 10.1161/01.cir.59.3.607
- Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959–969. DOI: 10.1016/s0735-1097(00)00804-4
- Thygesen K, Alpert JS, White HD; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Eur Heart J. 2007;28:2525–2538. DOI: 10.1093/eurheartj/ehm355
- Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581–1598. DOI: 10.1016/j.jacc.2012.08.001
- Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction (2018). Circulation. 2018;138:e618–e651. DOI: 10.1161/CIR.0000000000000617
- Byrne R, Coughlan JJ, Rossello X, Ibanez B; Members of the Task Force for the 2023 ESC Guidelines for the management of acute coronary syndromes. Key priorities for the implementation of the 2023 ESC Guidelines for the management of acute coronary syndromes in low-resource settings. Eur Heart J Qual Care Clin Outcomes. 2025;11:766–772. DOI: 10.1093/ehjqcco/qcae107
- Jennings RB, Ganote CE. Structural changes in myocardium during acute ischemia. Circ Res. 1974;35:156–172. DOI: 10.1161/res.35.3_supplement.iii-156
- Rossello X, Lobo-Gonzalez M, Ibanez B. Editor’s choice- Pathophysiology and therapy of myocardial ischaemia/reperfusion syndrome. Eur Heart J Acute Cardiovasc Care. 2019;8:443–456. DOI: 10.1177/2048872619845283
- Fanaroff AC, Rymer JA, Goldstein SA, Simel DL, Newby LK. Does this patient with chest pain have acute coronary syndrome?: The rational clinical examination systematic review. JAMA. 2015;314:1955–1965. DOI: 10.1001/jama.2015.12735
- Pasupathy S, Air T, Dreyer RP, Tavella R, Beltrame JF. Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries. Circulation. 2015;131:861–870. DOI: 10.1161/CIRCULATIONAHA.114.011201
- Shanmuganathan M, Nikolaidou C, Burrage MK, Borlotti A, Kotronias R, Scarsini R, et al. Cardiovascular magnetic resonance before invasive coronary angiography in suspected non-ST-segment elevation myocardial infarction. JACC Cardiovasc Imaging. 2024;17:1044–1058. DOI: 10.1016/j.jcmg.2024.05.007
- Shah ASV, Sandoval Y, Noaman A, Sexter A, Vaswani A, Smith SW, et al. Patient selection for high sensitivity cardiac troponin testing and diagnosis of myocardial infarction: prospective cohort study. BMJ. 2017;359:
j4788 . DOI: 10.1136/bmj.j4788 - Steiro OT, Langorgen J, Tjora HL, Bjorneklett RO, Skadberg O, Bonarjee VVS, et al. Prognostic significance of chronic myocardial injury diagnosed by three different cardiac troponin assays in patients admitted with suspected acute coronary syndrome. Clin Chem Lab Med. 2024;62:729–739. DOI: 10.1515/cclm-2023-0336
- Saeed N, Steiro OT, Langorgen J, Tjora HL, Bjorneklett RO, Skadberg O, et al. Diagnosing myocardial injury in an acute chest pain cohort; long-term prognostic implications of cardiac troponin T and I. Clin Chem. 2024;70:1241–1255. DOI: 10.1093/clinchem/hvae110
- DeFilippis AP, Chapman AR, Mills NL, de Lemos JA, Arbab-Zadeh A, Newby LK, et al. Assessment and treatment of patients with type 2 myocardial infarction and acute nonischemic myocardial injury. Circulation. 2019;140:1661–16678. DOI: 10.1161/CIRCULATIONAHA.119.040631
- Landesberg G, Jaffe AS, Gilon D, Levin PD, Goodman S, Abu-Baih A, et al. Troponin elevation in severe sepsis and septic shock: the role of left ventricular diastolic dysfunction and right ventricular dilatation. Crit Care Med. 2014;42:790–800. DOI: 10.1097/CCM.0000000000000107
- Singh T, Khan H, Gamble DT, Scally C, Newby DE, Dawson D. Takotsubo syndrome: pathophysiology, emerging concepts, and clinical implications. Circulation. 2022;145:1002–1019. DOI: 10.1161/CIRCULATIONAHA.121.055854
- Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, et al. Clinical features and outcomes of Takotsubo (stress) cardiomyopathy. N Engl J Med. 2015;373:929–938. DOI: 10.1056/NEJMoa1406761
- Eichhorn C, Greulich S, Bucciarelli-Ducci C, Sznitman R, Kwong RY, Gräni C. Multiparametric cardiovascular magnetic resonance approach in diagnosing, monitoring, and prognostication of myocarditis. JACC Cardiovasc Imaging. 2022;15:1325–1338. DOI: 10.1016/j.jcmg.2021.11.017
- Arnadottir A, Pedersen S, Bo Hasselbalch R, Goetze JP, Friis-Hansen LJ, Bloch-Munster AM, et al. Temporal release of high-sensitivity cardiac troponin T and I and copeptin after brief induced coronary artery balloon occlusion in humans. Circulation. 2021;143:1095–1104. DOI: 10.1161/CIRCULATIONAHA.120.046574
- Canty JM
Jr . Myocardial injury, troponin release, and cardiomyocyte death in brief ischemia, failure, and ventricular remodeling. Am J Physiol Heart Circ Physiol. 2022;323:H1–H15. DOI: 10.1152/ajpheart.00093.2022 - Mair J, Lindahl B, Hammarsten O, Muller C, Giannitsis E, Huber K, et al. How is cardiac troponin released from injured myocardium? Eur Heart J Acute Cardiovasc Care. 2018;7:553–560. DOI: 10.1177/2048872617748553
- Aengevaeren VL, Baggish AL, Chung EH, George K, Kleiven O, Mingels AMA, et al. Exercise-induced cardiac troponin elevations: from underlying mechanisms to clinical relevance. Circulation. 2021;144:1955–1972. DOI: 10.1161/CIRCULATIONAHA.121.056208
- Fridlich O, Peretz A, Fox-Fisher I, Pyanzin S, Dadon Z, Shcolnik E, et al. Elevated cfDNA after exercise is derived primarily from mature polymorphonuclear neutrophils, with a minor contribution of cardiomyocytes. Cell Rep Med. 2023;4:
101074 . DOI: 10.1016/j.xcrm.2023.101074 - Friden V, Starnberg K, Muslimovic A, Ricksten SE, Bjurman C, Forsgard N, et al. Clearance of cardiac troponin T with and without kidney function. Clin Biochem. 2017;50:468–474. DOI: 10.1016/j.clinbiochem.2017.02.007
- Muslimovic A, Friden V, Tenstad O, Starnberg K, Nystrom S, Wesen E, et al. The liver and kidneys mediate clearance of cardiac troponin in the rat. Sci Rep. 2020;10:
6791 . DOI: 10.1038/s41598-020-63744-8 - Zaman S, Wasfy JH, Kapil V, Ziaeian B, Parsonage WA, Sriswasdi S, et al. The Lancet Commission on rethinking coronary artery disease: moving from ischaemia to atheroma. Lancet. 2025;405:1264–1312. DOI: 10.1016/S0140-6736(25)00055-8
- Chin CW, Shah AS, McAllister DA, Joanna Cowell S, Alam S, Langrish JP, et al. High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis. Eur Heart J. 2014;35:2312–2321. DOI: 10.1093/eurheartj/ehu189
- Nellessen U, Goder S, Schobre R, Abawi M, Hecker H, Tschöke S. Serial analysis of troponin I levels in patients with ischemic and nonischemic dilated cardiomyopathy. Clin Cardiol. 2006;29:219–224. DOI: 10.1002/clc.4960290510
- Willinger L, Brudy L, Meyer M, Oberhoffer-Fritz R, Ewert P, Müller J. Prognostic value of non-acute high sensitive troponin-T for cardiovascular morbidity and mortality in adults with congenital heart disease: a systematic review. J Cardiol. 2021;78:206–212. DOI: 10.1016/j.jjcc.2021.02.008
- Eggers KM, Lindahl B. Application of cardiac troponin in cardiovascular diseases other than acute coronary syndrome. Clin Chem. 2017;63:223–235. DOI: 10.1373/clinchem.2016.261495
- Lindahl B, Thurston AJ, Tew YY, McDermott M, Fujisawa T, Lynch S, et al. Change in cardiac troponin T to differentiate acute from chronic myocardial injury in the emergency department. Clin Biochem. 2026;141:
111055 . DOI: 10.1016/j.clinbiochem.2025.111055 - Roos A, Edgren G. Using historical cardiac troponins to identify patients at a high risk of myocardial infarction. Heart. 2023;109:127–133. DOI: 10.1136/heartjnl-2022-321198
- Boeddinghaus J, Lopez-Ayala P, Thurston AJF, Lee KK, Tew YY, Doudesis D, et al. Cardiovascular risk across myocardial injury and infarction categories using the universal definition: an individual patient-level data meta-analysis. J Am Coll Cardiol. 2025;87:2282–2297. DOI: 10.1016/j.jacc.2025.11.043
- de Lemos JA, Newby LK, Mills NL. A proposal for modest revision of the definition of type 1 and type 2 myocardial infarction. Circulation. 2019;140:1773–1775. DOI: 10.1161/CIRCULATIONAHA.119.042157
- Lindahl B, Mills NL. A new clinical classification of acute myocardial infarction. Nat Med. 2023;29:2200–2205. DOI: 10.1038/s41591-023-02513-2
- Taggart C, Roos A, Kadesjo E, Anand A, Li Z, Doudesis D, et al. Application of the universal definition of myocardial infarction in clinical practice in Scotland and Sweden. JAMA Netw Open. 2024;7:
e245853 . DOI: 10.1001/jamanetworkopen.2024.5853 - Gard A, Lindahl B, Baron T. Impact of clinical diagnosis of myocardial infarction in patients with elevated cardiac troponin. Heart. 2023;109:1533–1541. DOI: 10.1136/heartjnl-2022-322298
- Devereaux PJ, Lamy A, Chan MTV, Allard RV, Lomivorotov VV, Landoni G, et al. High-sensitivity troponin I after cardiac surgery and 30-day mortality. N Engl J Med. 2022;386:827–836. DOI: 10.1056/NEJMoa2000803
- Gaudino M, Jaffe AS, Milojevic M, Sandoval Y, Devereaux PJ, Thygesen K, et al. Great debate: myocardial infarction after cardiac surgery must be redefined. Eur Heart J. 2024;45:4170–4177. DOI: 10.1093/eurheartj/ehae416
- Jaffe AS, Lindahl B, Giannitsis E, Mueller C, Cullen L, Hammarsten O, et al. ESC Study Group on Cardiac Biomarkers of the Association for Acute CardioVascular Care: a fond farewell at the retirement of CKMB. Eur Heart J. 2021;42:2260–2264. DOI: 10.1093/eurheartj/ehaa1079
- Ueki Y, Otsuka T, Bar S, Koskinas KC, Heg D, Haner J, et al. Frequency and outcomes of periprocedural MI in patients with chronic coronary syndromes undergoing PCI. J Am Coll Cardiol. 2022;79:513–526. DOI: 10.1016/j.jacc.2021.11.047
- Bulluck H, Paradies V, Barbato E, Baumbach A, Botker HE, Capodanno D, et al. Prognostically relevant periprocedural myocardial injury and infarction associated with percutaneous coronary interventions: a consensus document of the ESC Working Group on Cellular Biology of the Heart and European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2021;42:2630–2642. DOI: 10.1093/eurheartj/ehab271
- Gaudino M, Flather M, Capodanno D, Milojevic M, Bhatt DL, Biondi Zoccai G, et al. European Association of Cardio-Thoracic Surgery (EACTS) expert consensus statement on perioperative myocardial infarction after cardiac surgery. Eur J Cardiothorac Surg. 2024;65:e
zad415 . DOI: 10.1093/ejcts/ezad415 - Hara H, Serruys PW, Takahashi K, Kawashima H, Ono M, Gao C, et al. Impact of peri-procedural myocardial infarction on outcomes after revascularization. J Am Coll Cardiol. 2020;76:1622–1639. DOI: 10.1016/j.jacc.2020.08.009
- DeWood MA, Spores J, Notske R, Mouser LT, Burroughs R, Golden MS, et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 1980;303:897–902. DOI: 10.1056/NEJM198010163031601
- Khan AR, Golwala H, Tripathi A, Bin Abdulhak AA, Bavishi C, Riaz H, et al. Impact of total occlusion of culprit artery in acute non-ST elevation myocardial infarction: a systematic review and meta-analysis. Eur Heart J. 2017;38:3082–3089. DOI: 10.1093/eurheartj/ehx418
- McLaren J, de Alencar JN, Aslanger EK, Meyers HP, Smith SW. From ST-segment elevation MI to occlusion MI: the new paradigm shift in acute myocardial infarction. JACC Adv. 2024;3:
101314 . DOI: 10.1016/j.jacadv.2024.101314 - Ricci F, Martini C, Scordo DM, Rossi D, Gallina S, Fedorowski A, et al. ECG patterns of occlusion myocardial infarction: a narrative review. Ann Emerg Med. 2025;85:330–340. DOI: 10.1016/j.annemergmed.2024.11.019
- Spirito A, Vaisnora L, Papadis A, Iacovelli F, Sardu C, Selberg A, et al. Acute coronary occlusion in patients with non-ST-segment elevation out-of-hospital cardiac arrest. J Am Coll Cardiol. 2023;81:446–456. DOI: 10.1016/j.jacc.2022.10.039
- Miranda DF, Lobo AS, Walsh B, Sandoval Y, Smith SW. New insights into the use of the 12-lead electrocardiogram for diagnosing acute myocardial infarction in the emergency department. Can J Cardiol. 2018;34:132–145. DOI: 10.1016/j.cjca.2017.11.011
- Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque formation and rupture. Circ Res. 2014;114:1852–1866. DOI: 10.1161/CIRCRESAHA.114.302721
- Fahed AC, Jang IK. Plaque erosion and acute coronary syndromes: phenotype, molecular characteristics and future directions. Nat Rev Cardiol. 2021;18:724–734. DOI: 10.1038/s41569-021-00542-3
- Kubo T, Imanishi T, Takarada S, Kuroi A, Ueno S, Yamano T, et al. Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy. J Am Coll Cardiol. 2007;50:933–939. DOI: 10.1016/j.jacc.2007.04.082
- Falk E, Nakano M, Bentzon JF, Finn AV, Virmani R. Update on acute coronary syndromes: the pathologists’ view. Eur Heart J. 2013;34:719–728. DOI: 10.1093/eurheartj/ehs411
- Ambrose JA, Tannenbaum MA, Alexopoulos D, Hjemdahl-Monsen CE, Leavy J, Weiss M, et al. Angiographic progression of coronary artery disease and the development of myocardial infarction. J Am Coll Cardiol. 1988;12:56–62. DOI: 10.1016/0735-1097(88)90356-7
- Adlam D, Alfonso F, Maas A, Vrints C, Writing C. European Society of Cardiology, acute cardiovascular care association, SCAD study group: a position paper on spontaneous coronary artery dissection. Eur Heart J. 2018;39:3353–3368. DOI: 10.1093/eurheartj/ehy080
- Hayes SN, Kim ESH, Saw J, Adlam D, Arslanian-Engoren C, Economy KE, et al. Spontaneous coronary artery dissection: current state of the science: a scientific statement from the American Heart Association. Circulation. 2018;137:e523–e557. DOI: 10.1161/CIR.0000000000000564
- Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, et al. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the evaluation and diagnosis of chest pain: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;144:e368–e454. DOI: 10.1161/CIR.0000000000001030
- Tamis-Holland JE, Jneid H, Reynolds HR, Agewall S, Brilakis ES, Brown TM, et al. Contemporary diagnosis and management of patients with myocardial infarction in the absence of obstructive coronary artery disease: a scientific statement from the American Heart Association. Circulation. 2019;139:e891–e908. DOI: 10.1161/CIR.0000000000000670
- Chapman AR, Taggart C, Boeddinghaus J, Mills NL, Fox KAA. Type 2 myocardial infarction: challenges in diagnosis and treatment. Eur Heart J. 2025;46:504–517. DOI: 10.1093/eurheartj/ehae803
- Sandoval Y, Jaffe AS. Type 2 myocardial infarction: JACC review topic of the week. J Am Coll Cardiol. 2019;73:1846–1860. DOI: 10.1016/j.jacc.2019.02.018
- Shah AS, Anand A, Sandoval Y, Lee KK, Smith SW, Adamson PD, et al. High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet. 2015;386:2481–2488. DOI: 10.1016/S0140-6736(15)00391-8
- Saaby L, Poulsen TS, Hosbond S, Larsen TB, Pyndt Diederichsen AC, Hallas J, et al. Classification of myocardial infarction: frequency and features of type 2 myocardial infarction. Am J Med. 2013;126:789–797. DOI: 10.1016/j.amjmed.2013.02.029
- Bularga A, Taggart C, Mendusic F, Kimenai DM, Wereski R, Lowry MTH, et al. Assessment of oxygen supply-demand imbalance and outcomes among patients with type 2 myocardial infarction: a secondary analysis of the High-STEACS cluster randomized clinical trial. JAMA Netw Open. 2022;5:
e2220162 . DOI: 10.1001/jamanetworkopen.2022.20162 - Neumann JT, Sorensen NA, Rubsamen N, Ojeda F, Renne T, Qaderi V, et al. Discrimination of patients with type 2 myocardial infarction. Eur Heart J. 2017;38:3514–3520. DOI: 10.1093/eurheartj/ehx457
- Sarkisian L, Saaby L, Poulsen TS, Gerke O, Jangaard N, Hosbond S, et al. Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins. Am J Med. 2016;129:446.e5–446.e21. DOI: 10.1016/j.amjmed.2015.11.006
- Wereski R, Kimenai DM, Taggart C, Doudesis D, Lee KK, Lowry MTH, et al. Cardiac troponin thresholds and kinetics to differentiate myocardial injury and myocardial infarction. Circulation. 2021;144:528–538. DOI: 10.1161/CIRCULATIONAHA.121.054302
- Bularga A, Hung J, Daghem M, Stewart S, Taggart C, Wereski R, et al. Coronary artery and cardiac disease in patients with type 2 myocardial infarction: a prospective cohort study. Circulation. 2022;145:1188–1200. DOI: 10.1161/CIRCULATIONAHA.121.058542
- McCarthy C, Murphy S, Cohen JA, Rehman S, Jones-O’Connor M, Olshan DS, et al. Misclassification of myocardial injury as myocardial infarction: implications for assessing outcomes in value-based programs. JAMA Cardiol. 2019;4:460–464. DOI: 10.1001/jamacardio.2019.0716
- Boeddinghaus J, Bularga A, Taggart C, Wereski R, McDermott M, Thurston AJF, et al. Implications of a new clinical classification of acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2025;14:131–141. DOI: 10.1093/ehjacc/zuaf002
- McCarthy CP, Murphy SP, Amponsah DK, Rambarat PK, Lin C, Liu Y, et al. Coronary computed tomographic angiography with fractional flow reserve in patients with type 2 myocardial infarction. J Am Coll Cardiol. 2023;82:1676–1687. DOI: 10.1016/j.jacc.2023.08.020
- Ruetzler K, Smilowitz NR, Berger JS, Devereaux PJ, Maron BA, Newby LK, et al. Diagnosis and management of patients with myocardial injury after noncardiac surgery: a scientific statement from the American Heart Association. Circulation. 2021;144:e287–e305. DOI: 10.1161/CIR.0000000000001024
- Kurz DJ, Naegeli B, Bertel O. A double-blind, randomized study of the effect of immediate intravenous nitroglycerin on the incidence of postprocedural chest pain and minor myocardial necrosis after elective coronary stenting. Am Heart J. 2000;139:35–43. DOI: 10.1016/s0002-8703(00)90306-5
- Belley-Cote EP, Whitlock RP, Lamy A, Alhussein MM, Lomivorotov V, Brady K, et al. Association between electrocardiographic changes and myocardial injury or death after cardiac surgery. Can J Cardiol. 2025;41:2601–2610. DOI: 10.1016/j.cjca.2025.09.035
- Polzl L, Thielmann M, Cymorek S, Nagele F, Hirsch J, Graber M, et al. Impact of myocardial injury after coronary artery bypass grafting on long-term prognosis. Eur Heart J. 2022;43:2407–2417. DOI: 10.1093/eurheartj/ehac054
- Crescenzi G, Bove T, Pappalardo F, Scandroglio AM, Landoni G, Aletti G, et al. Clinical significance of a new Q wave after cardiac surgery. Eur J Cardiothorac Surg. 2004;25:1001–1005. DOI: 10.1016/j.ejcts.2004.02.030
- Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, et al. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2023;148:e9–e119. DOI: 10.1161/CIR.0000000000001168
- Heuts S, Gollmann-Tepekoylu C, Denessen EJS, Olsthoorn JR, Romeo JLR, Maessen JG, et al. Cardiac troponin release following coronary artery bypass grafting: mechanisms and clinical implications. Eur Heart J. 2023;44:100–112. DOI: 10.1093/eurheartj/ehac604
- Moussa ID, Klein LW, Shah B, Mehran R, Mack MJ, Brilakis ES, et al. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). J Am Coll Cardiol. 2013;62:1563–1570. DOI: 10.1016/j.jacc.2013.08.720
- Ndrepepa G, Colleran R, Braun S, Cassese S, Hieber J, Fusaro M, et al. High-sensitivity troponin T and mortality after elective percutaneous coronary intervention. J Am Coll Cardiol. 2016;68:2259–2268. DOI: 10.1016/j.jacc.2016.08.059
- Kini A, Marmur JD, Kini S, Dangas G, Cocke TP, Wallenstein S, et al. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention. J Am Coll Cardiol. 1999;34:663–671. DOI: 10.1016/s0735-1097(99)00298-3
- Garcia-Garcia HM, McFadden EP, Farb A, Mehran R, Stone GW, Spertus J, et al. Standardized end point definitions for coronary intervention trials: the Academic Research Consortium-2 consensus document. Eur Heart J. 2018;39:2192–2207. DOI: 10.1093/eurheartj/ehy223
- Armillotta M, Bergamaschi L, Paolisso P, Belmonte M, Angeli F, Sansonetti A, et al. Prognostic relevance of type 4a myocardial infarction and periprocedural myocardial injury in patients with non-ST-segment-elevation myocardial infarction. Circulation. 2025;151:760–772. DOI: 10.1161/CIRCULATIONAHA.124.070729
- Alam SR, Stirrat C, Spath N, Zamvar V, Pessotto R, Dweck MR, et al. Myocardial inflammation, injury and infarction during on-pump coronary artery bypass graft surgery. J Cardiothorac Surg. 2017;12:
115 . DOI: 10.1186/s13019-017-0681-6 - Omran H, Deutsch MA, Groezinger E, Zittermann A, Renner A, Neumann JT, et al. High-sensitivity cardiac troponin I after coronary artery bypass grafting for post-operative decision-making. Eur Heart J. 2022;43:2388–2403. DOI: 10.1093/eurheartj/ehab918
- Spirito A, Sartori S, Koshy AN, Feng Y, Vogel B, Baber U, et al. Mortality after procedural or spontaneous myocardial infarction. J Am Coll Cardiol. 2024;84:467–477. DOI: 10.1016/j.jacc.2024.04.061
- Jangaard N, Sarkisian L, Saaby L, Mikkelsen S, Lassen AM, Marcussen N, et al. Incidence, frequency, and clinical characteristics of type 3 myocardial infarction in clinical practice. Am J Med. 2017;130:862.e9–862.e14. DOI: 10.1016/j.amjmed.2016.12.034
- Wagensveld IM, Blokker BM, Pezzato A, Wielopolski PA, Renken NS, von der Thusen JH, et al. Diagnostic accuracy of postmortem computed tomography, magnetic resonance imaging, and computed tomography-guided biopsies for the detection of ischaemic heart disease in a hospital setting. Eur Heart J Cardiovasc Imaging. 2018;19:739–748. DOI: 10.1093/ehjci/jey015
- Stassi C, Mondello C, Baldino G, Cardia L, Gualniera P, Calapai F, et al. State of the art on the role of postmortem computed tomography angiography and magnetic resonance imaging in the diagnosis of cardiac causes of death: a narrative review. Tomography. 2022;8:961–973. DOI: 10.3390/tomography8020077
- Michaud K, Jacobsen C, Basso C, Banner J, Blokker BM, de Boer HH, et al. Application of postmortem imaging modalities in cases of sudden death due to cardiovascular diseases-current achievements and limitations from a pathology perspective: endorsed by the Association for European Cardiovascular Pathology and by the International Society of Forensic Radiology and Imaging. Virchows Archiv. 2023;482:385–406. DOI: 10.1007/s00428-022-03458-6
- Cau R, Saba L, Balestrieri A, Meloni A, Mannelli L, La Grutta L, et al. Photon-counting computed tomography in atherosclerotic plaque characterization. Diagnostics. 2024;14:
1065 . DOI: 10.3390/diagnostics14111065 - Kotronias RA, de Maria GL, Xie C, Thomas S, Chan K, Portolan L, et al. Benchmarking photon-counting computed tomography angiography against invasive assessment of coronary stenosis: implications for severely calcified coronaries. JACC Cardiovasc Imaging. 2025;18:572–585. DOI: 10.1016/j.jcmg.2024.11.005
- Gascho D, von Allmen A, Landsmann A, Hunermund T, Tappero C, Thali MJ, et al. Diagnostic value of T(1)- and T(2)-weighted 3-Tesla MRI for postmortem detection and age stage classification of myocardial infarction. Forensic Sci Med Pathol. 2024;20:14–22. DOI: 10.1007/s12024-023-00592-8
- Delewi R, Ijff G, van de Hoef TP, Hirsch A, Robbers LF, Nijveldt R, et al. Pathological Q waves in myocardial infarction in patients treated by primary PCI. JACC Cardiovasc Imaging. 2013;6:324–331. DOI: 10.1016/j.jcmg.2012.08.018
- Antiochos P, Ge Y, Steel K, Bingham S, Abdullah S, Mikolich JR, et al. Imaging of clinically unrecognized myocardial fibrosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 2020;76:945–957. DOI: 10.1016/j.jacc.2020.06.063
- Boland LL, Folsom AR, Sorlie PD, Taylor HA, Rosamond WD, Chambless LE, et al. Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (the ARIC study). Am J Cardiol. 2002;90:927–931. DOI: 10.1016/s0002-9149(02)02655-3
- Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation. 2006;113:2733–2743. DOI: 10.1161/CIRCULATIONAHA.105.570648
- Kwong RY, Sattar H, Wu H, Vorobiof G, Gandla V, Steel K, et al. Incidence and prognostic implication of unrecognized myocardial scar characterized by cardiac magnetic resonance in diabetic patients without clinical evidence of myocardial infarction. Circulation. 2008;118:1011–1020. DOI: 10.1161/CIRCULATIONAHA.107.727826
- Barbier CE, Bjerner T, Johansson L, Lind L, Ahlstrom H. Myocardial scars more frequent than expected: magnetic resonance imaging detects potential risk group. J Am Coll Cardiol. 2006;48:765–771. DOI: 10.1016/j.jacc.2006.05.041
- Fernandez-Friera L, Garcia-Alvarez A, Oliva B, Garcia-Lunar I, Garcia I, Moreno-Arciniegas A, et al. Association between subclinical atherosclerosis burden and unrecognized myocardial infarction detected by cardiac magnetic resonance in middle-aged low-risk adults. Eur Heart J Cardiovasc Imaging. 2024;25:968–975. DOI: 10.1093/ehjci/jeae044
- Hammar P, Nordenskjold AM, Lindahl B, Duvernoy O, Ahlstrom H, Johansson L, et al. Unrecognized myocardial infarctions assessed by cardiovascular magnetic resonance are associated with the severity of the stenosis in the supplying coronary artery. J Cardiovasc Magn Reson. 2015;17:
98 . DOI: 10.1186/s12968-015-0202-5 - Nordenskjold AM, Hammar P, Ahlstrom H, Bjerner T, Duvernoy O, Lindahl B. Unrecognized myocardial infarction assessed by cardiac magnetic resonance imaging is associated with adverse long-term prognosis. PLoS One. 2018;13:
e0200381 . DOI: 10.1371/journal.pone.0200381 - Braunwald E. Unstable angina. A classification. Circulation. 1989;80:410–414. DOI: 10.1161/01.cir.80.2.410
- Gerhardt W, Katus H, Ravkilde J, Hamm C, Jorgensen PJ, Peheim E, et al. S-troponin T in suspected ischemic myocardial injury compared with mass and catalytic concentrations of S-creatine kinase isoenzyme MB. Clin Chem. 1991;37:1405–1411. DOI: 10.1093/clinchem/37.8.1405
- Diderholm E, Andren B, Frostfeldt G, Genberg M, Jernberg T, Lagerqvist B, et al. The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC II invasive troponin T electrocardiogram substudy. Am Heart J. 2002;143:760–767. DOI: 10.1067/mhj.2002.121733
- Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L, for the FRISC Study Group. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med. 2000;343:1139–1147. DOI: 10.1056/NEJM200010193431602
- Morrow DA, Antman EM, Tanasijevic M, Rifai N, de Lemos JA, McCabe CH, et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol. 2000;36:1812–1817. DOI: 10.1016/s0735-1097(00)00942-6
- Braunwald E, Morrow DA. Unstable angina: is it time for a requiem? Circulation. 2013;127:2452–2457. DOI: 10.1161/CIRCULATIONAHA.113.001258
- Eggers KM, Jernberg T, Lindahl B. Unstable angina in the era of cardiac troponin assays with improved sensitivity—a clinical dilemma. Am J Med. 2017;130:1423–1430.e5. DOI: 10.1016/j.amjmed.2017.05.037
- Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017;38:143–153. DOI: 10.1093/eurheartj/ehw149
- Collet JP, Thiele H, Barbato E, Barthelemy O, Bauersachs J, Bhatt DL, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42:1289–1367. DOI: 10.1093/eurheartj/ehaa575
- Heitner JF, Senthilkumar A, Harrison JK, Klem I, Sketch MH Jr, Ivanov A, et al. Identifying the infarct-related artery in patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv. 2019;12:
e007305 . DOI: 10.1161/CIRCINTERVENTIONS.118.007305 - Reynolds HR, Maehara A, Kwong RY, Sedlak T, Saw J, Smilowitz NR, et al. Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women. Circulation. 2021;143:624–640. DOI: 10.1161/CIRCULATIONAHA.120.052008
- Liang K, Bisaccia G, Leo I, Williams MGL, Dastidar A, Strange JW, et al. CMR reclassifies the majority of patients with suspected MINOCA and non MINOCA. Eur Heart J Cardiovasc Imaging. 2023;25:8–15. DOI: 10.1093/ehjci/jead182
- Mileva N, Paolisso P, Gallinoro E, Fabbricatore D, Munhoz D, Bergamaschi L, et al. Diagnostic and prognostic role of cardiac magnetic resonance in MINOCA: systematic review and meta-analysis. JACC Cardiovasc Imaging. 2023;16:376–389. DOI: 10.1016/j.jcmg.2022.12.029
- Rajwani A, Giudicatti L, Telyuk P, Maredia N, Ihdayhid A, Chieng D, et al. Clinical impact of cardiac magnetic resonance imaging in myocardial infarction with non-obstructive coronary arteries: a prospective multicentre cohort study. Heart. 2026;112:95–102. DOI: 10.1136/heartjnl-2024-325181
- Williams MGL, Liang K, De Garate E, Spagnoli L, Fiori E, Dastidar A, et al. Peak troponin and CMR to guide management in suspected ACS and nonobstructive coronary arteries. JACC Cardiovasc Imaging. 2022;15:1578–1587. DOI: 10.1016/j.jcmg.2022.03.017
- Schulz-Menger J, Collini V, Groschel J, Adler Y, Brucato A, Christian V, et al. 2025 ESC Guidelines for the management of myocarditis and pericarditis. Eur Heart J. 2025;46:3952–4041. DOI: 10.1093/eurheartj/ehaf192
- Dastidar AG, Baritussio A, De Garate E, Drobni Z, Biglino G, Singhal P, et al. Prognostic role of CMR and conventional risk factors in myocardial infarction with nonobstructed coronary arteries. JACC Cardiovasc Imaging. 2019;12:1973–1982. DOI: 10.1016/j.jcmg.2018.12.023
- Anderson HVS, Masri SC, Abdallah MS, Chang AM, Cohen MG, Elgendy IY, et al. 2022 ACC/AHA key data elements and definitions for chest pain and acute myocardial infarction: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Data Standards. Circ Cardiovasc Qual Outcomes. 2022;15:
e000112 . DOI: 10.1161/HCQ.0000000000000112 - Angerud KH, Sederholm Lawesson S, Isaksson RM, Thylen I, Swahn E. Differences in symptoms, first medical contact and pre-hospital delay times between patients with ST- and non-ST-elevation myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2019;8:201–207. DOI: 10.1177/2048872617741734
- Lichtman JH, Leifheit EC, Safdar B, Bao H, Krumholz HM, Lorenze NP, et al. Sex differences in the presentation and perception of symptoms among young patients with myocardial infarction: evidence from the VIRGO study (Variation in Recovery: Role of Gender on Outcomes of young AMI patients). Circulation. 2018;137:781–790. DOI: 10.1161/CIRCULATIONAHA.117.031650
- Devon HA, Rosenfeld A, Steffen AD, Daya M. Sensitivity, specificity, and sex differences in symptoms reported on the 13-item acute coronary syndrome checklist. J Am Heart Assoc. 2014;3:
e000586 . DOI: 10.1161/JAHA.113.000586 - Ferry AV, Anand A, Strachan FE, Mooney L, Stewart SD, Marshall L, et al. Presenting symptoms in men and women diagnosed with myocardial infarction using sex-specific criteria. J Am Heart Assoc. 2019;8:
e012307 . DOI: 10.1161/JAHA.119.012307 - Brieger D, Eagle KA, Goodman SG, Steg PG, Budaj A, White K, et al. Acute coronary syndromes without chest pain, an underdiagnosed and undertreated high-risk group: insights from the Global Registry of Acute Coronary Events. Chest. 2004;126:461–469. DOI: 10.1378/chest.126.2.461
- Canto AJ, Kiefe CI, Goldberg RJ, Rogers WJ, Peterson ED, Wenger NK, et al. Differences in symptom presentation and hospital mortality according to type of acute myocardial infarction. Am Heart J. 2012;163:572–579. DOI: 10.1016/j.ahj.2012.01.020
- Galinski M, Saget D, Ruscev M, Gonzalez G, Ameur L, Lapostolle F, et al. Chest pain in an out-of-hospital emergency setting: no relationship between pain severity and diagnosis of acute myocardial infarction. Pain Pract. 2015;15:343–347. DOI: 10.1111/papr.12178
- Khan IA, Karim HMR, Panda CK, Ahmed G, Nayak S. Atypical presentations of myocardial infarction: a systematic review of case reports. Cureus. 2023;15:
e35492 . DOI: 10.7759/cureus.35492 - Kirchberger I, Meisinger C, Heier M, Kling B, Wende R, Greschik C, et al. Patient-reported symptoms in acute myocardial infarction: differences related to ST-segment elevation: the MONICA/KORA Myocardial Infarction Registry. J Intern Med. 2011;270:58–64. DOI: 10.1111/j.1365-2796.2011.02365.x
- Stehli J, Martin C, Brennan A, Dinh DT, Lefkovits J, Zaman S. Sex differences persist in time to presentation, revascularization, and mortality in myocardial infarction treated with percutaneous coronary intervention. J Am Heart Assoc. 2019;8:
e012161 . DOI: 10.1161/JAHA.119.012161 - van Oosterhout REM, de Boer AR, Maas A, Rutten FH, Bots ML, Peters SAE. Sex differences in symptom presentation in acute coronary syndromes: a systematic review and meta-analysis. J Am Heart Assoc. 2020;9:
e014733 . DOI: 10.1161/JAHA.119.014733 - DeVon HA, Vuckovic K, Burke LA, Mirzaei S, Breen K, Robinson N, et al. What’s the risk? Older women report fewer symptoms for suspected acute coronary syndrome than younger women. Biores Open Access. 2018;7:131–138. DOI: 10.1089/biores.2018.0020
- Bjorck L, Nielsen S, Jernberg T, Zverkova-Sandstrom T, Giang KW, Rosengren A. Absence of chest pain and long-term mortality in patients with acute myocardial infarction. Open Heart. 2018;5:
e000909 . DOI: 10.1136/openhrt-2018-000909 - Kumar A, Sanghera A, Sanghera B, Mohamed T, Midgen A, Pattison S, et al. Chest pain symptoms during myocardial infarction in patients with and without diabetes: a systematic review and meta-analysis. Heart. 2023;109:1516–1524. DOI: 10.1136/heartjnl-2022-322289
- Nanna MG, Hajduk AM, Krumholz HM, Murphy TE, Dreyer RP, Alexander KP, et al. Sex-based differences in presentation, treatment, and complications among older adults hospitalized for acute myocardial infarction: the SILVER-AMI study. Circ Cardiovasc Qual Outcomes. 2019;12:
e005691 . DOI: 10.1161/CIRCOUTCOMES.119.005691 - Øhrn AM, Nielsen CS, Schirmer H, Stubhaug A, Wilsgaard T, Lindekleiv H. Pain tolerance in persons with recognized and unrecognized myocardial infarction: a population-based, cross-sectional study. J Am Heart Assoc. 2016;5:
e003846 . DOI: 10.1161/JAHA.116.003846 - DeVon HA, Burke LA, Nelson H, Zerwic JJ, Riley B. Disparities in patients presenting to the emergency department with potential acute coronary syndrome: it matters if you are Black or White. Heart Lung. 2014;43:270–277. DOI: 10.1016/j.hrtlng.2014.04.019
- King-Shier K, Quan H, Kapral MK, Tsuyuki R, An L, Banerjee S, et al. Acute coronary syndromes presentations and care outcomes in white, South Asian and Chinese patients: a cohort study. BMJ Open. 2019;9:
e022479 . DOI: 10.1136/bmjopen-2018-022479 - Jinatongthai P, Kongwatcharapong J, Foo CY, Phrommintikul A, Nathisuwan S, Thakkinstian A, et al. Comparative efficacy and safety of reperfusion therapy with fibrinolytic agents in patients with ST-segment elevation myocardial infarction: a systematic review and network meta-analysis. Lancet. 2017;390:747–759. DOI: 10.1016/S0140-6736(17)31441-1
- Widimsky P, Rohac F, Stasek J, Kala P, Rokyta R, Kuzmanov B, et al. Primary angioplasty in acute myocardial infarction with right bundle branch block: should new onset right bundle branch block be added to future guidelines as an indication for reperfusion therapy? Eur Heart J. 2012;33:86–95. DOI: 10.1093/eurheartj/ehr291
- Sgarbossa EB, Pinski SL, Barbagelata A, Underwood DA, Gates KB, Topol EJ, et al. Electrocardiographic diagnosis of evolving acute myocardial infarction in the presence of left bundle-branch block. GUSTO-1 (Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries) investigators. N Engl J Med. 1996;334:481–487. DOI: 10.1056/NEJM199602223340801
- Smith SW, Dodd KW, Henry TD, Dvorak DM, Pearce LA. Diagnosis of ST-elevation myocardial infarction in the presence of left bundle branch block with the ST-elevation to S-wave ratio in a modified Sgarbossa rule. Ann Emerg Med. 2012;60:766–776. DOI: 10.1016/j.annemergmed.2012.07.119
- de Winter RJ, Verouden NJ, Wellens HJ, Wilde AA; Interventional Cardiology Group of the Academic Medical Center. A new ECG sign of proximal LAD occlusion. N Engl J Med. 2008;359:2071–2073. DOI: 10.1056/NEJMc0804737
- de Zwaan C, Bär FW, Wellens HJ. Characteristic electrocardiographic pattern indicating a critical stenosis high in left anterior descending coronary artery in patients admitted because of impending myocardial infarction. Am Heart J. 1982;103:730–736. DOI: 10.1016/0002-8703(82)90480-x
- Rossello X, Wiegerinck RF, Alguersuari J, Bardaji A, Worner F, Sutil M, et al. New electrocardiographic criteria to differentiate acute pericarditis and myocardial infarction. Am J Med. 2014;127:233–239. DOI: 10.1016/j.amjmed.2013.11.006
- Raitt MH, Maynard C, Wagner GS, Cerqueira MD, Selvester RH, Weaver WD. Appearance of abnormal Q waves early in the course of acute myocardial infarction: implications for efficacy of thrombolytic therapy. J Am Coll Cardiol. 1995;25:1084–1088. DOI: 10.1016/0735-1097(94)00514-q
- Krone RJ, Friedman E, Thanavaro S, Miller JP, Kleiger RE, Oliver GC. Long-term prognosis after first Q-wave (transmural) or non-Q-wave (nontransmural) myocardial infarction: analysis of 593 patients. Am J Cardiol. 1983;52:234–239. DOI: 10.1016/0002-9149(83)90114-5
- Westermann D, Neumann JT, Sörensen NA, Blankenberg S. High-sensitivity assays for troponin in patients with cardiac disease. Nat Rev Cardiol. 2017;14:472–483. DOI: 10.1038/nrcardio.2017.48
- Vylegzhanina AV, Kogan AE, Katrukha IA, Koshkina EV, Bereznikova AV, Filatov VL, et al. Full-size and partially truncated cardiac troponin complexes in the blood of patients with acute myocardial infarction. Clin Chem. 2019;65:882–892. DOI: 10.1373/clinchem.2018.301127
- Kristensen JH, Hasselbalch RB, Strandkjaer N, Jorgensen N, Ostergaard M, Moller-Sorensen PH, et al. Half-life and clearance of cardiac troponin I and troponin T in humans. Circulation. 2024;150:1187–1198. DOI: 10.1161/CIRCULATIONAHA.123.066565
- International Federation of Clinical Chemistry and Laboratory Medicine. Biomarkers Reference Tables. High Sensitivity Cardiac Troponin I and T Assay Analytical Characteristics.
https://ifcc.org/ifcc-education-division/emd-committees/committee-on-clinical-applications-of-cardiac-bio-markers-c-cb/biomarkers-reference-tables (13 April 2026, date last accessed). - Apple FS, Collinson PO; IFCC Task Force on Clinical Applications of Cardiac Biomarkers. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem. 2012;58:54–61. DOI: 10.1373/clinchem.2011.165795
- Collinson P, Hammerer-Lercher A, Aakre KM, Gruson D, Suvisaari J, Pulkki K, et al. Implementation of high sensitivity troponin into routine clinical practice—results of the extended CARdiac MArkers guideline uptake in Europe group (CARMAGUE) survey. Clin Chim Acta. 2024;558:
117900 . DOI: 10.1016/j.cca.2024.117900 - Aakre KM, Saenger AK, Body R, Collinson P, Hammarsten O, Jaffe AS, et al. Analytical considerations in deriving 99th percentile upper reference limits for high-sensitivity cardiac troponin assays: educational recommendations from the IFCC Committee on Clinical Application of Cardiac Bio-Markers. Clin Chem. 2022;68:1022–1030. DOI: 10.1093/clinchem/hvac092
- McEvoy JW, Tang O, Wang D, Ndumele CE, Coresh J, Christenson RH, et al. Myocardial injury thresholds for 4 high-sensitivity troponin assays in U.S. adults. J Am Coll Cardiol. 2023;81:2028–2039. DOI: 10.1016/j.jacc.2023.03.403
- Welsh P, Preiss D, Shah ASV, McAllister D, Briggs A, Boachie C, et al. Comparison between high-sensitivity cardiac troponin T and cardiac troponin I in a large general population cohort. Clin Chem. 2018;64:1607–1616. DOI: 10.1373/clinchem.2018.292086
- Cao M, Pierce AE, Norman MS, Thakur B, Diercks K, Hale C, et al. Systematic review of sex-specific high sensitivity cardiac troponin I and T thresholds. Clin Ther. 2024;46:988–994. DOI: 10.1016/j.clinthera.2024.09.025
- Kimenai DM, Janssen E, Eggers KM, Lindahl B, den Ruijter HM, Bekers O, et al. Sex-specific versus overall clinical decision limits for cardiac troponin I and T for the diagnosis of acute myocardial infarction: a systematic review. Clin Chem. 2018;64:1034–1043. DOI: 10.1373/clinchem.2018.286781
- Shah AS, Griffiths M, Lee KK, McAllister DA, Hunter AL, Ferry AV, et al. High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ. 2015;350:
g7873 . DOI: 10.1136/bmj.g7873 - Rubini Gimenez M, Twerenbold R, Boeddinghaus J, Nestelberger T, Puelacher C, Hillinger P, et al. Clinical effect of sex-specific cutoff values of high-sensitivity cardiac troponin T in suspected myocardial infarction. JAMA Cardiol. 2016;1:912–920. DOI: 10.1001/jamacardio.2016.2882
- Daniels LB, Mueller C, Giannitsis E, Meex SJR, Buehlmann D, Dilba P, et al. Establishing reference values in healthy participants for the cardiac troponin T high-sensitivity gen 6 assay: REF-TSIX global reference study. Clin Chem. 2026;72:488–502. DOI: 10.1093/clinchem/hvag011
- de Bakker M, Anand A, Shipley M, Fujisawa T, Shah ASV, Kardys I, et al. Sex differences in cardiac troponin trajectories over the life course. Circulation. 2023;147:1798–1808. DOI: 10.1161/CIRCULATIONAHA.123.064386
- Lowry MTH, Doudesis D, Wereski R, Kimenai DM, Tuck C, Ferry AV, et al. Influence of age on the diagnosis of myocardial infarction. Circulation. 2022;146:1135–1148. DOI: 10.1161/CIRCULATIONAHA.122.059994
- Doudesis D, Lee KK, Boeddinghaus J, Bularga A, Ferry AV, Tuck C, et al. Machine learning for diagnosis of myocardial infarction using cardiac troponin concentrations. Nat Med. 2023;29:1201–1210. DOI: 10.1038/s41591-023-02325-4
- Hammarsten O, Warner JV, Lam L, Kavsak P, Lindahl B, Aakre KM, et al. Antibody-mediated interferences affecting cardiac troponin assays: recommendations from the IFCC Committee on Clinical Applications of Cardiac Biomarkers. Clin Chem Lab Med. 2023;61:1411–1419. DOI: 10.1515/cclm-2023-0028
- Harley K, Bissonnette S, Inzitari R, Schulz K, Apple FS, Kavsak PA, et al. Independent and combined effects of biotin and hemolysis on high-sensitivity cardiac troponin assays. Clin Chem Lab Med. 2021;59:1431–1443. DOI: 10.1515/cclm-2021-0124
- Herman DS, Kavsak PA, Greene DN. Variability and error in cardiac troponin testing: an ACLPS critical review. Am J Clin Pathol. 2017;148:281–295. DOI: 10.1093/ajcp/aqx066
- Christenson RH, Frenk LDS, de Graaf HJ, van Domburg TSY, Wijnands FPG, Foolen HWJ, et al. Point-of-care: roadmap for analytical characterization and validation of a high-sensitivity cardiac troponin I assay in plasma and whole blood matrices. J Appl Lab Med. 2022;7:971–988. DOI: 10.1093/jalm/jfac028
- Chaulin AM. False-positive causes in serum cardiac troponin levels. J Clin Med Res. 2022;14:80–87. DOI: 10.14740/jocmr4664
- Salaun E, Drory S, Cote MA, Tremblay V, Bedard E, Steinberg C, et al. Role of antitroponin antibodies and macrotroponin in the clinical interpretation of cardiac troponin. J Am Heart Assoc. 2024;13:
e035128 . DOI: 10.1161/JAHA.123.035128 - Mair J, Giannitsis E, Mills NL, Mueller C; Study Group on Biomarkers of the European Society of Cardiology Association for Acute CardioVascular Care. How to deal with unexpected cardiac troponin results. Eur Heart J Acute Cardiovasc Care. 2022;11:e1–e3. DOI: 10.1093/ehjacc/zuac023
- Bularga A, Oskoui E, Fujisawa T, Jenks S, Sutherland R, Apple FS, et al. Macrotroponin complex as a cause for cardiac troponin increase after COVID-19 vaccination and infection. Clin Chem. 2022;68:1015–1019. DOI: 10.1093/clinchem/hvac100
- Lam L, Tse R, Gladding P, Kyle C. Effect of macrotroponin in a cohort of community patients with elevated cardiac troponin. Clin Chem. 2022;68:1261–1271. DOI: 10.1093/clinchem/hvac118
- Jaffe AS, Body R, Mills NL, Aakre KM, Collinson PO, Saenger A, et al. Single troponin measurement to rule out myocardial infarction: JACC review topic of the week. J Am Coll Cardiol. 2023;82:60–69. DOI: 10.1016/j.jacc.2023.04.040
- Hoeller R, Rubini Gimenez M, Reichlin T, Twerenbold R, Zellweger C, Moehring B, et al. Normal presenting levels of high-sensitivity troponin and myocardial infarction. Heart. 2013;99:1567–1572. DOI: 10.1136/heartjnl-2013-303643
- Lowry MTH, Doudesis D, Boeddinghaus J, Kimenai DM, Bularga A, Taggart C, et al. Troponin in early presenters to rule out myocardial infarction. Eur Heart J. 2023;44:2846–2858. DOI: 10.1093/eurheartj/ehad376
- Wereski R, Chapman AR, Lee KK, Smith SW, Lowe DJ, Gray A, et al. High-sensitivity cardiac troponin concentrations at presentation in patients with ST-segment elevation myocardial infarction. JAMA Cardiol. 2020;5:1302–1304. DOI: 10.1001/jamacardio.2020.2867
- Liu T, Howarth AG, Chen Y, Nair AR, Yang HJ, Ren D, et al. Intramyocardial hemorrhage and the “wave front” of reperfusion injury compromising myocardial salvage. J Am Coll Cardiol. 2022;79:35–48. DOI: 10.1016/j.jacc.2021.10.034
- Vora KP, Kalra A, Shah CD, Bhatt K, Kumar A, Pandya T, et al. In-hospital mortality in hemorrhagic myocardial infarction. NEJM Evid. 2025;4:
EVIDoa2400294 . DOI: 10.1056/EVIDoa2400294 - Silvain J, Zeitouni M, Paradies V, Zheng HL, Ndrepepa G, Cavallini C, et al. Procedural myocardial injury, infarction and mortality in patients undergoing elective PCI: a pooled analysis of patient-level data. Eur Heart J. 2021;42:323–334. DOI: 10.1093/eurheartj/ehaa885
- Miller WL, Garratt KN, Burritt MF, Reeder GS, Jaffe AS. Timing of peak troponin T and creatine kinase-MB elevations after percutaneous coronary intervention. Chest. 2004;125:275–280. DOI: 10.1378/chest.125.1.275
- Miller WL, Garratt KN, Burritt MF, Lennon RJ, Reeder GS, Jaffe AS. Baseline troponin level: key to understanding the importance of post-PCI troponin elevations. Eur Heart J. 2006;27:1061–1069. DOI: 10.1093/eurheartj/ehi760
- Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, et al. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation. 2005;111:1027–1032. DOI: 10.1161/01.CIR.0000156328.28485.AD
- Eggers KM, Batra G, Lindahl B, Ghukasyan Lakic T, Lindback J, Budaj A, et al. Temporal biomarker concentration patterns during the early course of acute coronary syndrome. Clin Chem Lab Med. 2024;62:1167–1176. DOI: 10.1515/cclm-2023-1253
- Jaffe AS, Moeckel M, Giannitsis E, Huber K, Mair J, Mueller C, et al. In search for the Holy Grail: suggestions for studies to define delta changes to diagnose or exclude acute myocardial infarction: a position paper from the study group on biomarkers of the Acute Cardiovascular Care Association. Eur Heart J Acute Cardiovasc Care. 2014;3:313–316. DOI: 10.1177/2048872614541906
- Reichlin T, Irfan A, Twerenbold R, Reiter M, Hochholzer W, Burkhalter H, et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation. 2011;124:136–145. DOI: 10.1161/CIRCULATIONAHA.111.023937
- Hollander JE, Than M, Mueller C. State-of-the-art evaluation of emergency department patients presenting with potential acute coronary syndromes. Circulation. 2016;134:547–564. DOI: 10.1161/CIRCULATIONAHA.116.021886
- Lowry MTH, Anand A, Mills NL. Implementing an early rule-out pathway for acute myocardial infarction in clinical practice. Heart. 2021;107:1912–1919. DOI: 10.1136/heartjnl-2019-316242
- Writing C, Kontos MC, de Lemos JA, Deitelzweig SB, Diercks DB, Gore MO, et al. 2022 ACC expert consensus decision pathway on the evaluation and disposition of acute chest pain in the emergency department: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022;80:1925–1960. DOI: 10.1016/j.jacc.2022.08.750
- Reichlin T, Schindler C, Drexler B, Twerenbold R, Reiter M, Zellweger C, et al. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med. 2012;172:1211–1218. DOI: 10.1001/archinternmed.2012.3698
- Baker JO, Tyther R, Liebetrau C, Clark J, Howarth R, Patterson T, et al. Cardiac myosin-binding protein C: a potential early biomarker of myocardial injury. Basic Res Cardiol. 2015;110:
23 . DOI: 10.1007/s00395-015-0478-5 - Kaier TE, Twerenbold R, Lopez-Ayala P, Nestelberger T, Boeddinghaus J, Alaour B, et al. A 0/1h-algorithm using cardiac myosin-binding protein C for early diagnosis of myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2022;11:325–335. DOI: 10.1093/ehjacc/zuac007
- Kaier TE, Twerenbold R, Puelacher C, Marjot J, Imambaccus N, Boeddinghaus J, et al. Direct comparison of cardiac myosin-binding protein C with cardiac troponins for the early diagnosis of acute myocardial infarction. Circulation. 2017;136:1495–1508. DOI: 10.1161/CIRCULATIONAHA.117.028084
- Iqbal J, Sumaya W, Tatman V, Parviz Y, Morton AC, Grech ED, et al. Incidence and predictors of stent thrombosis: a single-centre study of 5,833 consecutive patients undergoing coronary artery stenting. EuroIntervention. 2013;9:62–69. DOI: 10.4244/EIJV9I1A10
- Moussa ID, Mohananey D, Saucedo J, Stone GW, Yeh RW, Kennedy KF, et al. Trends and outcomes of restenosis after coronary stent implantation in the United States. J Am Coll Cardiol. 2020;76:1521–1531. DOI: 10.1016/j.jacc.2020.08.002
- Popovic B, Agrinier N, Bouchahda N, Pinelli S, Maigrat CH, Metzdorf PA, et al. Coronary embolism among ST-segment-elevation myocardial infarction patients: mechanisms and management. Circ Cardiovasc Interv. 2018;11:
e005587 . DOI: 10.1161/CIRCINTERVENTIONS.117.005587 - Wang J, Gao H, Xiao J, Gao M, Liu Y, Gao J. The clinical features and prognosis of type 4C myocardial infarction in patients with non-ST-segment elevation myocardial infarction. Ann Transl Med. 2021;9:
1153 . DOI: 10.21037/atm-21-2587 - Balbi MM, Scarparo P, Tovar MN, Masdjedi K, Daemen J, Den Dekker W, et al. Culprit lesion detection in patients presenting with non-ST elevation acute coronary syndrome and multivessel disease. Cardiovasc Revasc Med. 2022;35:110–118. DOI: 10.1016/j.carrev.2021.03.019
- Kerensky RA, Wade M, Deedwania P, Boden WE, Pepine CJ; Veterans Affairs Non-Q-Wave Infarction Strategies in-Hospital (VANQWISH) Trial Investigators. Revisiting the culprit lesion in non-Q-wave myocardial infarction. Results from the VANQWISH trial angiographic core laboratory. J Am Coll Cardiol. 2002;39:1456–1463. DOI: 10.1016/s0735-1097(02)01770-9
- Andersson HB, Pedersen F, Engstrom T, Helqvist S, Jensen MK, Jorgensen E, et al. Long-term survival and causes of death in patients with ST-elevation acute coronary syndrome without obstructive coronary artery disease. Eur Heart J. 2018;39:102–110. DOI: 10.1093/eurheartj/ehx491
- Gehrie ER, Reynolds HR, Chen AY, Neelon BH, Roe MT, Gibler WB, et al. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative. Am Heart J. 2009;158:688–694. DOI: 10.1016/j.ahj.2009.08.004
- Larsen AI, Nilsen DW, Yu J, Mehran R, Nikolsky E, Lansky AJ, et al. Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial). Am J Cardiol. 2013;111:643–648. DOI: 10.1016/j.amjcard.2012.11.011
- Johnson TW, Raber L, di Mario C, Bourantas C, Jia H, Mattesini A, et al. Clinical use of intracoronary imaging. Part 2: Acute coronary syndromes, ambiguous coronary angiography findings, and guiding interventional decision-making: an expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J. 2019;40:2566–2584. DOI: 10.1093/eurheartj/ehz332
- De Bruyne B, Pijls NH, Kalesan B, Barbato E, Tonino PA, Piroth Z, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367:991–1001. DOI: 10.1056/NEJMoa1205361
- Eftekhari A, Holck EN, Westra J, Olsen NT, Bruun NH, Jensen LO, et al. Instantaneous wave free ratio vs. fractional flow reserve and 5-year mortality: iFR SWEDEHEART and DEFINE FLAIR. Eur Heart J. 2023;44:4376–4384. DOI: 10.1093/eurheartj/ehad582
- Masdjedi K, van Zandvoort LJC, Balbi MM, Gijsen FJH, Ligthart JMR, Rutten MCM, et al. Validation of a three-dimensional quantitative coronary angiography-based software to calculate fractional flow reserve: the FAST study. EuroIntervention. 2020;16:591–599. DOI: 10.4244/EIJ-D-19-00466
- Kontos MC. Role of echocardiography in the emergency department for identifying patients with myocardial infarction and ischemia. Echocardiography. 1999;16:193–205. DOI: 10.1111/j.1540-8175.1999.tb00804.x
- Rybicki FJ, Udelson JE, Peacock WF, Goldhaber SZ, Isselbacher EM, Kazerooni E, et al. 2015 ACR/ACC/AHA/AATS/ACEP/ASNC/NASCI/SAEM/SCCT/SCMR/SCPC/SNMMI/STR/STS appropriate utilization of cardiovascular imaging in emergency department patients with chest pain: a joint document of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Appropriate Use Criteria Task Force. J Am Coll Cardiol. 2016;67:853–879. DOI: 10.1016/j.jacc.2015.09.011
- Stillman AE, Oudkerk M, Bluemke D, Bremerich J, Esteves FP, Garcia EV, et al. Assessment of acute myocardial infarction: current status and recommendations from the North American Society for Cardiovascular Imaging and the European Society of Cardiac Radiology. Int J Cardiovasc Imaging. 2011;27:7–24. DOI: 10.1007/s10554-010-9714-0
- Thune JJ, Kober L, Pfeffer MA, Skali H, Anavekar NS, Bourgoun M, et al. Comparison of regional versus global assessment of left ventricular function in patients with left ventricular dysfunction, heart failure, or both after myocardial infarction: the valsartan in acute myocardial infarction echocardiographic study. J Am Soc Echocardiogr. 2006;19:1462–1465. DOI: 10.1016/j.echo.2006.05.028
- Kontos MC, Diercks DB, Kirk JD. Emergency department and office-based evaluation of patients with chest pain. Mayo Clin Proc. 2010;85:284–299. DOI: 10.4065/mcp.2009.0560
- Lewis WR. Echocardiography in the evaluation of patients in chest pain units. Cardiol Clin. 2005;23:531–539, vii. DOI: 10.1016/j.ccl.2005.08.009
- Scirica BM. Acute coronary syndrome: emerging tools for diagnosis and risk assessment. J Am Coll Cardiol. 2010;55:1403–1415. DOI: 10.1016/j.jacc.2009.09.071
- Geers J, Balfour A, Molek P, Barron P, Botezatu S, Joshi SS, et al. Systematic hand-held echocardiography in patients hospitalized with acute coronary syndrome. Eur Heart J Cardiovasc Imaging. 2024;25:1441–1450. DOI: 10.1093/ehjci/jeae149
- Korosoglou G, Geiger B, Hansen A, Hardt SA, Giannitsis E, Selter C, et al. Usefulness of real-time myocardial perfusion imaging to evaluate alterations of myocardial blood flow in patients with stable angina pectoris undergoing elective percutaneous coronary interventions. Am J Cardiol. 2005;96:885–891. DOI: 10.1016/j.amjcard.2005.05.041
- Mair J, Jaffe A, Lindahl B, Mills N, Mockel M, Cullen L, et al. The clinical approach to diagnosing peri-procedural myocardial infarction after percutaneous coronary interventions according to the fourth universal definition of myocardial infarction—from the study group on biomarkers of the European Society of Cardiology (ESC) Association for Acute CardioVascular Care (ACVC). Biomarkers. 2022;27:407–417. DOI: 10.1080/1354750X.2022.2055792
- Doolub G, Khurshid S, Theriault-Lauzier P, Nolin Lapalme A, Tastet O, So D, et al. Revolutionising acute cardiac care with artificial intelligence: opportunities and challenges. Can J Cardiol. 2024;40:1813–1827. DOI: 10.1016/j.cjca.2024.06.011
- Kusunose K, Abe T, Haga A, Fukuda D, Yamada H, Harada M, et al. A deep learning approach for assessment of regional wall motion abnormality from echocardiographic images. JACC Cardiovasc Imaging. 2020;13:374–381. DOI: 10.1016/j.jcmg.2019.02.024
- Laumer F, Di Vece D, Cammann VL, Wurdinger M, Petkova V, Schonberger M, et al. Assessment of artificial intelligence in echocardiography diagnostics in differentiating Takotsubo syndrome from myocardial infarction. JAMA Cardiol. 2022;7:494–503. DOI: 10.1001/jamacardio.2022.0183
- Upton R, Mumith A, Beqiri A, Parker A, Hawkes W, Gao S, et al. Automated echocardiographic detection of severe coronary artery disease using artificial intelligence. JACC Cardiovasc Imaging. 2022;15:715–727. DOI: 10.1016/j.jcmg.2021.10.013
- Ibanez B, Aletras AH, Arai AE, Arheden H, Bax J, Berry C, et al. Cardiac MRI endpoints in myocardial infarction experimental and clinical trials: JACC scientific expert panel. J Am Coll Cardiol. 2019;74:238–256. DOI: 10.1016/j.jacc.2019.05.024
- Vora KP, Kumar A, Krishnam MS, Prato FS, Raman SV, Dharmakumar R. Microvascular obstruction and intramyocardial hemorrhage in reperfused myocardial infarctions: pathophysiology and clinical insights from imaging. JACC Cardiovasc Imaging. 2024;17:795–810. DOI: 10.1016/j.jcmg.2024.02.003
- Rossello X, Lopez-Ayala P, Fernandez-Jimenez R, Oliver E, Galan-Arriola C, de Molina-Iracheta A, et al. R2 prime (R2’) magnetic resonance imaging for post-myocardial infarction intramyocardial haemorrhage quantification. Eur Heart J Cardiovasc Imaging. 2020;21:1031–1038. DOI: 10.1093/ehjci/jez306
- Abdel-Aty H, Zagrosek A, Schulz-Menger J, Taylor AJ, Messroghli D, Kumar A, et al. Delayed enhancement and T2-weighted cardiovascular magnetic resonance imaging differentiate acute from chronic myocardial infarction. Circulation. 2004;109:2411–2416. DOI: 10.1161/01.CIR.0000127428.10985.C6
- Bulluck H, Rosmini S, Abdel-Gadir A, White SK, Bhuva AN, Treibel TA, et al. Residual myocardial iron following intramyocardial hemorrhage during the convalescent phase of reperfused ST-segment-elevation myocardial infarction and adverse left ventricular remodeling. Circ Cardiovasc Imaging. 2016;9:
e004940 . DOI: 10.1161/CIRCIMAGING.116.004940 - Wang G, Yang HJ, Kali A, Cokic I, Tang R, Xie G, et al. Influence of myocardial hemorrhage on staging of reperfused myocardial infarctions with T(2) cardiac magnetic resonance imaging: insights into the dependence on infarction type with ex vivo validation. JACC Cardiovasc Imaging. 2019;12:693–703. DOI: 10.1016/j.jcmg.2018.01.018
- Ganame J, Messalli G, Dymarkowski S, Rademakers FE, Desmet W, Van de Werf F, et al. Impact of myocardial haemorrhage on left ventricular function and remodelling in patients with reperfused acute myocardial infarction. Eur Heart J. 2009;30:1440–1449. DOI: 10.1093/eurheartj/ehp093
- Kumar A, Connelly K, Vora K, Bainey KR, Howarth A, Leipsic J, et al. The Canadian Cardiovascular Society classification of acute atherothrombotic myocardial infarction based on stages of tissue injury severity: an expert consensus statement. Can J Cardiol. 2024;40:1–14. DOI: 10.1016/j.cjca.2023.09.020
- Lechner I, Reindl M, Stiermaier T, Tiller C, Holzknecht M, Oberhollenzer F, et al. Clinical outcomes associated with various microvascular injury patterns identified by CMR after STEMI. J Am Coll Cardiol. 2024;83:2052–2062. DOI: 10.1016/j.jacc.2024.03.408
- Vyas R, Changal KH, Bhuta S, Pasadyn V, Katterle K, Niedoba MJ, et al. Impact of intramyocardial hemorrhage on clinical outcomes in ST-elevation myocardial infarction: a systematic review and meta-analysis. J Soc Cardiovasc Angiogr Interv. 2022;1:
100444 . DOI: 10.1016/j.jscai.2022.100444 - Wu KC, Zerhouni EA, Judd RM, Lugo-Olivieri CH, Barouch LA, Schulman SP, et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998;97:765–772. DOI: 10.1161/01.cir.97.8.765
- Locca D, Bucciarelli-Ducci C, Ferrante G, La Manna A, Keenan NG, Grasso A, et al. New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions? JACC Cardiovasc Interv. 2010;3:950–958. DOI: 10.1016/j.jcin.2010.06.015
- Hwang HY, Yeom SY, Park EA, Lee W, Jang MJ, Kim KB. Serial cardiac magnetic resonance imaging after surgical coronary revascularization for left ventricular dysfunction. J Thorac Cardiovasc Surg. 2020;159:1798–1805. DOI: 10.1016/j.jtcvs.2019.04.109
- Kolossvary M, Szilveszter B, Merkely B, Maurovich-Horvat P. Plaque imaging with CT—a comprehensive review on coronary CT angiography based risk assessment. Cardiovasc Diagn Ther. 2017;7:489–506. DOI: 10.21037/cdt.2016.11.06
- Puchner SB, Liu T, Mayrhofer T, Truong QA, Lee H, Fleg JL, et al. High-risk plaque detected on coronary CT angiography predicts acute coronary syndromes independent of significant stenosis in acute chest pain: results from the ROMICAT-II trial. J Am Coll Cardiol. 2014;64:684–692. DOI: 10.1016/j.jacc.2014.05.039
- Kofoed KF, Engstrom T, Sigvardsen PE, Linde JJ, Torp-Pedersen C, de Knegt M, et al. Prognostic value of coronary CT angiography in patients with non-ST-segment elevation acute coronary syndromes. J Am Coll Cardiol. 2021;77:1044–1052. DOI: 10.1016/j.jacc.2020.12.037
- Gray AJ, Roobottom C, Smith JE, Goodacre S, Oatey K, O’Brien R, et al. Early computed tomography coronary angiography in patients with suspected acute coronary syndrome: randomised controlled trial. BMJ. 2021;374:
n2106 . DOI: 10.1136/bmj.n2106 - Meah MN, Bularga A, Tzolos E, Chapman AR, Daghem M, Hung JD, et al. Distinguishing type 1 from type 2 myocardial infarction by using CT coronary angiography. Radiol Cardiothorac Imaging. 2022;4:
e220081 . DOI: 10.1148/ryct.220081 - Pergola V, Continisio S, Mantovani F, Motta R, Mattesi G, Marrazzo G, et al. Spontaneous coronary artery dissection: the emerging role of coronary computed tomography. Eur Heart J Cardiovasc Imaging. 2023;24:839–850. DOI: 10.1093/ehjci/jead060
- Dai N, Chen Z, Zhou F, Zhou Y, Hu N, Duan S, et al. Coronary CT angiography-derived plaque characteristics and physiologic patterns for peri-procedural myocardial infarction and subsequent events. Eur Heart J Cardiovasc Imaging. 2023;24:897–908. DOI: 10.1093/ehjci/jead025
- Serruys PW, Kageyama S, Pompilio G, Andreini D, Pontone G, Mushtaq S, et al. Coronary bypass surgery guided by computed tomography in a low-risk population. Eur Heart J. 2024;45:1804–1815. DOI: 10.1093/eurheartj/ehae199
- Palmisano A, Vignale D, Tadic M, Moroni F, De Stefano D, Gatti M, et al. Myocardial late contrast enhancement CT in troponin-positive acute chest pain syndrome. Radiology. 2022;302:545–553. DOI: 10.1148/radiol.211288
- Çitaku H, Miftari R, Stubljar D, Krasniqi X. Size of acute myocardial infarction correlates with earlier time of initiation of reperfusion therapy with cardiac perfusion scintigraphy: a national single-center study. Med Sci Monit Basic Res. 2021;27:
e933214 . DOI: 10.12659/MSMBR.933214 - Wagner A, Mahrholdt H, Holly TA, Elliott MD, Regenfus M, Parker M, et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarcts: an imaging study. Lancet. 2003;361:374–379. DOI: 10.1016/S0140-6736(03)12389-6
- Wells RG. Instrumentation in molecular imaging. J Nucl Cardiol. 2016;23:1343–1347. DOI: 10.1007/s12350-016-0498-z
- Tzolos E, Bing R, Andrews J, MacAskill MG, Tavares AAS, Macnaught G, et al. Noninvasive in vivo coronary artery thrombus imaging. JACC Cardiovasc Imaging. 2023;16:820–832. DOI: 10.1016/j.jcmg.2022.10.002
- Tzolos E, Bing R, Newby DE, Dweck MR. Categorising myocardial infarction with advanced cardiovascular imaging. Lancet. 2021;398:
e9 . DOI: 10.1016/S0140-6736(21)01329-5 - Gibson CM, Karha J, Murphy SA, James D, Morrow DA, Cannon CP, et al. Early and long-term clinical outcomes associated with reinfarction following fibrinolytic administration in the thrombolysis in myocardial infarction trials. J Am Coll Cardiol. 2003;42:7–16. DOI: 10.1016/s0735-1097(03)00506-0
- Kernis SJ, Harjai KJ, Stone GW, Grines LL, Boura JA, Yerkey MW, et al. The incidence, predictors, and outcomes of early reinfarction after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol. 2003;42:1173–1177. DOI: 10.1016/s0735-1097(03)00920-3
- Nair R, Johnson M, Kravitz K, Huded C, Rajeswaran J, Anabila M, et al. Characteristics and outcomes of early recurrent myocardial infarction after acute myocardial infarction. J Am Heart Assoc. 2021;10:
e019270 . DOI: 10.1161/JAHA.120.019270 - Song J, Murugiah K, Hu S, Gao Y, Li X, Krumholz HM, et al. Incidence, predictors, and prognostic impact of recurrent acute myocardial infarction in China. Heart. 2021;107:313–318. DOI: 10.1136/heartjnl-2020-317165
- Holzmann MJ, Andersson T, Doemland ML, Roux S. Recurrent myocardial infarction and emergency department visits: a retrospective study on the Stockholm Area Chest Pain Cohort. Open Heart. 2023;10:
e002206 . DOI: 10.1136/openhrt-2022-002206 - Stromback U, Engstrom A, Lundqvist R, Lundblad D, Vikman I. The second myocardial infarction: is there any difference in symptoms and prehospital delay compared to the first myocardial infarction? Eur J Cardiovasc Nurs. 2018;17:652–659. DOI: 10.1177/1474515118777391
- Kwok CS, Bennett S, Azam Z, Welsh V, Potluri R, Loke YK, et al. Misdiagnosis of acute myocardial infarction: a systematic review of the literature. Crit Pathw Cardiol. 2021;20:155–162. DOI: 10.1097/HPC.0000000000000256
- Adamson PD, McAllister D, Pilbrow A, Pickering JW, Poppe K, Shah A, et al. Convalescent troponin and cardiovascular death following acute coronary syndrome. Heart. 2019;105:1717–1724. DOI: 10.1136/heartjnl-2019-315084
- Apple FS, Murakami MM. Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction. Clin Chem. 2005;51:460–463. DOI: 10.1373/clinchem.2004.042887
- Ekstrom K, Nepper-Christensen L, Ahtarovski KA, Kyhl K, Goransson C, Bertelsen L, et al. Impact of multiple myocardial scars detected by CMR in patients following STEMI. JACC Cardiovasc Imaging. 2019;12:2168–2178. DOI: 10.1016/j.jcmg.2019.01.032
- Kociol RD, Pang PS, Gheorghiade M, Fonarow GC, O’Connor CM, Felker GM. Troponin elevation in heart failure prevalence, mechanisms, and clinical implications. J Am Coll Cardiol. 2010;56:1071–1078. DOI: 10.1016/j.jacc.2010.06.016
- Felker GM, Mentz RJ, Teerlink JR, Voors AA, Pang PS, Ponikowski P, et al. Serial high sensitivity cardiac troponin T measurement in acute heart failure: insights from the RELAX-AHF study. Eur J Heart Fail. 2015;17:1262–1270. DOI: 10.1002/ejhf.341
- Januzzi JL Jr, Filippatos G, Nieminen M, Gheorghiade M. Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section. Eur Heart J. 2012;33:2265–2271. DOI: 10.1093/eurheartj/ehs191
- Weil BR, Suzuki G, Young RF, Iyer V, Canty, JM
Jr . Troponin release and reversible left ventricular dysfunction after transient pressure overload. J Am Coll Cardiol. 2018;71:2906–2916. DOI: 10.1016/j.jacc.2018.04.029 - Aimo A, Januzzi JL Jr, Vergaro G, Ripoli A, Latini R, Masson S, et al. Prognostic value of high-sensitivity troponin T in chronic heart failure: an individual patient data meta-analysis. Circulation. 2018;137:286–297. DOI: 10.1161/CIRCULATIONAHA.117.031560
- Frank Peacock W
4th , De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, et al. Cardiac troponin and outcome in acute heart failure. N Engl J Med. 2008;358:2117–2126. DOI: 10.1056/NEJMoa0706824 - Packer M, Januzzi JL, Ferreira JP, Anker SD, Butler J, Filippatos G, et al. Concentration-dependent clinical and prognostic importance of high-sensitivity cardiac troponin T in heart failure and a reduced ejection fraction and the influence of empagliflozin: the EMPEROR-Reduced trial. Eur J Heart Fail. 2021;23:1529–1538. DOI: 10.1002/ejhf.2256
- McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42:3599–3726. DOI: 10.1093/eurheartj/ehab368
- Gallacher PJ, Yeung D, Bell S, Shah ASV, Mills NL, Dhaun N. Kidney replacement therapy: trends in incidence, treatment, and outcomes of myocardial infarction and stroke in a nationwide Scottish study. Eur Heart J. 2024;45:1339–1351. DOI: 10.1093/eurheartj/ehae080
- Szummer K, Lundman P, Jacobson SH, Schon S, Lindback J, Stenestrand U, et al. Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register. J Intern Med. 2010;268:40–49. DOI: 10.1111/j.1365-2796.2009.02204.x
- Gallacher PJ, Miller-Hodges E, Shah ASV, Anand A, Dhaun N, Mills NL, et al. Use of high-sensitivity cardiac troponin in patients with kidney impairment: a randomized clinical trial. JAMA Intern Med. 2021;181:1237–1239. DOI: 10.1001/jamainternmed.2021.1184
- Keddis MT, El-Zoghby ZM, El Ters M, Rodrigo E, Pellikka PA, Jaffe AS, et al. Cardiac troponin T before and after kidney transplantation: determinants and implications for posttransplant survival. Am J Transplant. 2013;13:406–414. DOI: 10.1111/j.1600-6143.2012.04317.x
- van der Linden N, Cornelis T, Kimenai DM, Klinkenberg LJJ, Hilderink JM, Luck S, et al. Origin of cardiac troponin T elevations in chronic kidney disease. Circulation. 2017;136:1073–1075. DOI: 10.1161/CIRCULATIONAHA.117.029986
- Matsushita K, Ballew SH, Wang AY, Kalyesubula R, Schaeffner E, Agarwal R. Epidemiology and risk of cardiovascular disease in populations with chronic kidney disease. Nat Rev Nephrol. 2022;18:696–707. DOI: 10.1038/s41581-022-00616-6
- Ndumele CE, Neeland IJ, Tuttle KR, Chow SL, Mathew RO, Khan SS, et al. A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association. Circulation. 2023;148:1636–1664. DOI: 10.1161/CIR.0000000000001186
- Brunner FJ, Kroger F, Blaum C, Gossling A, Lorenz T, van Erckelens E, et al. Association of high-sensitivity troponin T and I with the severity of stable coronary artery disease in patients with chronic kidney disease. Atherosclerosis. 2020;313:81–87. DOI: 10.1016/j.atherosclerosis.2020.09.024
- deFilippi C, Seliger SL, Kelley W, Duh SH, Hise M, Christenson RH, et al. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clin Chem. 2012;58:1342–1351. DOI: 10.1373/clinchem.2012.185322
- Knott JD, Ola O, De Michieli L, Akula A, Mehta RA, Dworak M, et al. Diagnosis of acute myocardial infarction in patients with renal failure using high-sensitivity cardiac troponin T. Eur Heart J Acute Cardiovasc Care. 2024;13:546–558. DOI: 10.1093/ehjacc/zuae079
- Miller-Hodges E, Anand A, Shah ASV, Chapman AR, Gallacher P, Lee KK, et al. High-sensitivity cardiac troponin and the risk stratification of patients with renal impairment presenting with suspected acute coronary syndrome. Circulation. 2018;137:425–435. DOI: 10.1161/CIRCULATIONAHA.117.030320
- Twerenbold R, Badertscher P, Boeddinghaus J, Nestelberger T, Wildi K, Puelacher C, et al. 0/1-Hour triage algorithm for myocardial infarction in patients with renal dysfunction. Circulation. 2018;137:436–451. DOI: 10.1161/CIRCULATIONAHA.117.028901
- Gallacher PJ, Miller-Hodges E, Shah ASV, Farrah TE, Halbesma N, Blackmur JP, et al. High-sensitivity cardiac troponin and the diagnosis of myocardial infarction in patients with kidney impairment. Kidney Int. 2022;102:149–159. DOI: 10.1016/j.kint.2022.02.019
- Davenport MS, Perazella MA, Yee J, Dillman JR, Fine D, McDonald RJ, et al. Use of intravenous iodinated contrast media in patients with kidney disease: consensus statements from the American College of Radiology and the National Kidney Foundation. Radiology. 2020;294:660–668. DOI: 10.1148/radiol.2019192094
- Maslove DM, Tang B, Shankar-Hari M, Lawler PR, Angus DC, Baillie JK, et al. Redefining critical illness. Nat Med. 2022;28:1141–1148. DOI: 10.1038/s41591-022-01843-x
- Pastores SM, Dulu A, Voigt L, Raoof N, Alicea M, Halpern NA. Premortem clinical diagnoses and postmortem autopsy findings: discrepancies in critically ill cancer patients. Critical Care. 2007;11:
R48 . DOI: 10.1186/cc5782 - Perkins GD, McAuley DF, Davies S, Gao F. Discrepancies between clinical and postmortem diagnoses in critically ill patients: an observational study. Critical Care. 2003;7:R129–R132. DOI: 10.1186/cc2359
- Roosen J, Frans E, Wilmer A, Knockaert DC, Bobbaers H. Comparison of premortem clinical diagnoses in critically ill patients and subsequent autopsy findings. Mayo Clin Proc. 2000;75:562–567. DOI: 10.4065/75.6.562
- Docherty AB, Alam S, Shah AS, Moss A, Newby DE, Mills NL, et al. Unrecognised myocardial infarction and its relationship to outcome in critically ill patients with cardiovascular disease. Intensive Care Med. 2018;44:2059–2069. DOI: 10.1007/s00134-018-5425-0
- Lim W, Holinski P, Devereaux PJ, Tkaczyk A, McDonald E, Clarke F, et al. Detecting myocardial infarction in critical illness using screening troponin measurements and ECG recordings. Critical Care. 2008;12:
R36 . DOI: 10.1186/cc6815 - Rennyson SL, Hunt J, Haley MW, Norton HJ, Littmann L. Electrocardiographic ST-segment elevation myocardial infarction in critically ill patients: an observational cohort analysis. Crit Care Med. 2010;38:2304–2309. DOI: 10.1097/CCM.0b013e3181fa02cd
- Lim W, Qushmaq I, Cook DJ, Devereaux PJ, Heels-Ansdell D, Crowther MA, et al. Reliability of electrocardiogram interpretation in critically ill patients. Crit Care Med. 2006;34:1338–1343. DOI: 10.1097/01.CCM.0000214679.23957.90
- Marcelino PA, Marum SM, Fernandes AP, Germano N, Lopes MG. Routine transthoracic echocardiography in a general intensive care unit: an 18 month survey in 704 patients. Eur J Intern Med. 2009;20:e37–e42. DOI: 10.1016/j.ejim.2008.09.015
- Cavefors O, Holmqvist J, Bech-Hanssen O, Einarsson F, Norberg E, Lundin S, et al. Regional left ventricular systolic dysfunction associated with critical illness: incidence and effect on outcome. ESC Heart Fail. 2021;8:5415–5423. DOI: 10.1002/ehf2.13633
- Champion S, Belcour D, Vandroux D, Drouet D, Gauzere BA, Bouchet B, et al. Stress (Tako-tsubo) cardiomyopathy in critically-ill patients. Eur Heart J Acute Cardiovasc Care. 2015;4:189–196. DOI: 10.1177/2048872614547686
- Vallabhajosyula S, Deshmukh AJ, Kashani K, Prasad A, Sakhuja A. Tako-tsubo cardiomyopathy in severe sepsis: nationwide trends, predictors, and outcomes. J Am Heart Assoc. 2018;7:
e009160 . DOI: 10.1161/JAHA.118.009160 - Murata M, Nakagawa N, Kawasaki T, Yasuo S, Yoshida T, Ando K, et al. Adverse events during intrahospital transport of critically ill patients: a systematic review and meta-analysis. Am J Emerg Med. 2022;52:13–19. DOI: 10.1016/j.ajem.2021.11.021
- Parmentier-Decrucq E, Poissy J, Favory R, Nseir S, Onimus T, Guerry MJ, et al. Adverse events during intrahospital transport of critically ill patients: incidence and risk factors. Ann Intensive Care. 2013;3:
10 . DOI: 10.1186/2110-5820-3-10 - Halvorsen S, Mehilli J, Cassese S, Hall TS, Abdelhamid M, Barbato E, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery. Eur Heart J. 2022;43:3826–3924. DOI: 10.1093/eurheartj/ehac270
- Devereaux PJ, Xavier D, Pogue J, Guyatt G, Sigamani A, Garutti I, et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med. 2011;154:523–528. DOI: 10.7326/0003-4819-154-8-201104190-00003
- Puelacher C, Gualandro DM, Glarner N, Lurati Buse G, Lampart A, Bolliger D, et al. Long-term outcomes of perioperative myocardial infarction/injury after non-cardiac surgery. Eur Heart J. 2023;44:1690–1701. DOI: 10.1093/eurheartj/ehac798
- Smilowitz NR, Redel-Traub G, Hausvater A, Armanious A, Nicholson J, Puelacher C, et al. Myocardial injury after noncardiac surgery: a systematic review and meta-analysis. Cardiol Rev. 2019;27:267–273. DOI: 10.1097/CRD.0000000000000254
- Writing Committee for the VISION Study Investigators; Devereaux PJ, Biccard BM, Sigamani A, Xavier D, Chan MTV, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery. JAMA. 2017;317:1642–1651. DOI: 10.1001/jama.2017.4360
- Thompson A, Fleischmann KE, Smilowitz NR, de Las Fuentes L, Mukherjee D, Aggarwal NR, et al. 2024 AHA/ACC/ACS/ASNC/HRS/SCA/SCCT/SCMR/SVM Guideline for perioperative cardiovascular management for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2024;150:e351–e442. DOI: 10.1161/CIR.0000000000001285
- Nagele P, Brown F, Gage BF, Gibson DW, Miller JP, Jaffe AS, et al. High-sensitivity cardiac troponin T in prediction and diagnosis of myocardial infarction and long-term mortality after noncardiac surgery. Am Heart J. 2013;166:325–332.e1. DOI: 10.1016/j.ahj.2013.04.018
- Genereux P, Head SJ, Van Mieghem NM, Kodali S, Kirtane AJ, Xu K, et al. Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012;59:2317–2326. DOI: 10.1016/j.jacc.2012.02.022
- Ribeiro HB, Webb JG, Makkar RR, Cohen MG, Kapadia SR, Kodali S, et al. Predictive factors, management, and clinical outcomes of coronary obstruction following transcatheter aortic valve implantation: insights from a large multicenter registry. J Am Coll Cardiol. 2013;62:1552–1562. DOI: 10.1016/j.jacc.2013.07.040
- Akuka A, Landes U, Manevich L, Rubinshtein R, Danenberg HD. Coronary embolism after transcatheter aortic valve replacement-case series and review of literature. Am J Cardiol. 2023;205:234–240. DOI: 10.1016/j.amjcard.2023.07.137
- Kim WK, Rolf A, Liebetrau C, Van Linden A, Blumenstein J, Kempfert J, et al. Detection of myocardial injury by CMR after transcatheter aortic valve replacement. J Am Coll Cardiol. 2014;64:349–357. DOI: 10.1016/j.jacc.2014.03.052
- Real C, Avvedimento M, Nuche J, Franzone A, Farjat-Pasos J, Trinh KH, et al. Myocardial injury after transcatheter aortic valve replacement according to VARC-3 criteria. JACC Cardiovasc Interv. 2023;16:1221–1232. DOI: 10.1016/j.jcin.2023.03.022
- Ribeiro HB, Nombela-Franco L, Munoz-Garcia AJ, Lemos PA, Amat-Santos I, Serra V, et al. Predictors and impact of myocardial injury after transcatheter aortic valve replacement: a multicenter registry. J Am Coll Cardiol. 2015;66:2075–2088. DOI: 10.1016/j.jacc.2015.08.881
- Rodes-Cabau J, Gutierrez M, Bagur R, De Larochelliere R, Doyle D, Cote M, et al. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol. 2011;57:1988–1999. DOI: 10.1016/j.jacc.2010.11.060
- Sinning JM, Hammerstingl C, Schueler R, Neugebauer A, Keul S, Ghanem A, et al. The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation. EuroIntervention. 2016;11:1522–1529. DOI: 10.4244/EIJY15M02_02
- Tocchetti CG, Farmakis D, Koop Y, Andres MS, Couch LS, Formisano L, et al. Cardiovascular toxicities of immune therapies for cancer—a scientific statement of the Heart Failure Association (HFA) of the ESC and the ESC Council of Cardio-Oncology. Eur J Heart Fail. 2024;26:2055–2076. DOI: 10.1002/ejhf.3340
- Cardinale D, Sandri MT, Colombo A, Colombo N, Boeri M, Lamantia G, et al. Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy. Circulation. 2004;109:2749–2754. DOI: 10.1161/01.CIR.0000130926.51766.CC
- Tzolos E, Adamson PD, Hall PS, Macpherson IR, Oikonomidou O, MacLean M, et al. Dynamic changes in high-sensitivity cardiac troponin I in response to anthracycline-based chemotherapy. Clin Oncol. 2020;32:292–297. DOI: 10.1016/j.clon.2019.11.008
- Lyon AR, Lopez-Fernandez T, Couch LS, Asteggiano R, Aznar MC, Bergler-Klein J, et al. 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS). Eur Heart J. 2022;43:4229–4361. DOI: 10.1093/eurheartj/ehac244
- Jiang C, Xu H, Wu Y. Effect of chemotherapy in tumor on coronary arteries: mechanisms and management. Life Sci. 2024;338:
122377 . DOI: 10.1016/j.lfs.2023.122377 - Junehag L, Asplund K, Svedlund M. A qualitative study: perceptions of the psychosocial consequences and access to support after an acute myocardial infarction. Intensive Crit Care Nurs. 2014;30:22–30. DOI: 10.1016/j.iccn.2013.07.002
- Gwaltney C, Reaney M, Krohe M, Martin MM, Falvey H, Mollon P. Symptoms and functional limitations in the first year following a myocardial infarction: a qualitative study. Patient. 2017;10:225–235. DOI: 10.1007/s40271-016-0194-8
- Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, et al. Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 2014;129:1350–1369. DOI: 10.1161/CIR.0000000000000019
- Murphy B, Le Grande M, Alvarenga M, Worcester M, Jackson A. Anxiety and depression after a cardiac event: prevalence and predictors. Front Psychol. 2020;10:
3010 . DOI: 10.3389/fpsyg.2019.03010 - Legler SR, Beale EE, Celano CM, Beach SR, Healy BC, Huffman JC. State gratitude for one’s life and health after an acute coronary syndrome: prospective associations with physical activity, medical adherence and re-hospitalizations. J Posit Psychol. 2019;14:283–291. DOI: 10.1080/17439760.2017.1414295
- Dreyer RP, Pavlo AJ, Horne A, Dunn R, Danvers K, Brush J, et al. Conceptual framework for personal recovery in patients with acute myocardial infarction. J Am Heart Assoc. 2021;10:
e022354 . DOI: 10.1161/JAHA.121.022354 - Sjostrom-Strand A, Ivarsson B, Sjoberg T. Women’s experience of a myocardial infarction: 5 years later. Scand J Caring Sci. 2011;25:459–466. DOI: 10.1111/j.1471-6712.2010.00849.x
- Rossello X, Pocock SJ, Julian DG. Long-term use of cardiovascular drugs: challenges for research and for patient care. J Am Coll Cardiol. 2015;66:1273–1285. DOI: 10.1016/j.jacc.2015.07.018
- Smedegaard L, Numé AK, Charlot M, Kragholm K, Gislason G, Hansen PR. Return to work and risk of subsequent detachment from employment after myocardial infarction: insights from Danish nationwide registries. J Am Heart Assoc. 2017;6:
e006486 . DOI: 10.1161/JAHA.117.006486 - Boudrez H, De Backer G. Recent findings on return to work after an acute myocardial infarction or coronary artery bypass grafting. Acta Cardiol. 2000;55:341–349. DOI: 10.2143/AC.55.6.2005765
- Mittag O, Kolenda KD, Nordman KJ, Bernien J, Maurischat C. Return to work after myocardial infarction/coronary artery bypass grafting: patients’ and physicians’ initial viewpoints and outcome 12 months later. Soc Sci Med. 2001;52:1441–1450. DOI: 10.1016/s0277-9536(00)00250-1
- Sepehrvand N, Zheng Y, Armstrong PW, Welsh R, Goodman SG, Tymchak W, et al. Alignment of site versus adjudication committee-based diagnosis with patient outcomes: insights from the Providing Rapid Out of Hospital Acute Cardiovascular Treatment 3 trial. Clinical Trials. 2016;13:140–148. DOI: 10.1177/1740774515601437
- McCarthy CP, Murphy S, Cohen JA, Rehman S, Jones-O’Connor M, Olshan DS, et al. Underutilization of cardiac rehabilitation for type 2 myocardial infarction. J Am Coll Cardiol. 2019;73:2005–2007. DOI: 10.1016/j.jacc.2019.01.032
- Zeymer U, Goss F, Kunadt M, Oldenburg S, Hochadel M, Thiele H, et al. Patient knowledge about risk factors, achievement of target values, and guideline-adherent secondary prevention therapies 12 months after acute myocardial infarction. Eur Heart J Acute Cardiovasc Care. 2024;13:537–545. DOI: 10.1093/ehjacc/zuae066
- Hertz JT, Sakita FM, Manavalan P, Mmbaga BT, Thielman NM, Staton CA. Knowledge, attitudes, and preventative practices regarding ischemic heart disease among emergency department patients in northern Tanzania. Public Health. 2019;175:60–67. DOI: 10.1016/j.puhe.2019.06.017
- Gallagher R, Roach K, Belshaw J, Kirkness A, Sadler L, Warrington D. A pre-test post-test study of a brief educational intervention demonstrates improved knowledge of potential acute myocardial infarction symptoms and appropriate responses in cardiac rehabilitation patients. Aust Crit Care. 2013;26:49–54. DOI: 10.1016/j.aucc.2012.01.002
- Redfern J, Hyun K, Chew DP, Astley C, Chow C, Aliprandi-Costa B, et al. Prescription of secondary prevention medications, lifestyle advice, and referral to rehabilitation among acute coronary syndrome inpatients: results from a large prospective audit in Australia and New Zealand. Heart. 2014;100:1281–1288. DOI: 10.1136/heartjnl-2013-305296
- Albarqouni L, Smenes K, Meinertz T, Schunkert H, Fang X, Ronel J, et al. Patients’ knowledge about symptoms and adequate behaviour during acute myocardial infarction and its impact on delay time: findings from the multicentre MEDEA study. Patient Educ Couns. 2016;99:1845–1851. DOI: 10.1016/j.pec.2016.06.007
- Grace SL, Turk-Adawi KI, Contractor A, Atrey A, Campbell NR, Derman W, et al. Cardiac rehabilitation delivery model for low-resource settings: an International Council of Cardiovascular Prevention and Rehabilitation consensus statement. Prog Cardiovasc Dis. 2016;59:303–322. DOI: 10.1016/j.pcad.2016.08.004
- Chapman AR, Adamson PD, Shah ASV, Anand A, Strachan FE, Ferry AV, et al. High-sensitivity cardiac troponin and the universal definition of myocardial infarction. Circulation. 2020;141:161–171. DOI: 10.1161/CIRCULATIONAHA.119.042960
- Thygesen K, Jaffe AS. Adjusting the MI codes into the framework of the universal definition of myocardial infarction. J Am Coll Cardiol. 2021;77:858–860. DOI: 10.1016/j.jacc.2021.01.003
- GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204–1222. DOI: 10.1016/S0140-6736(20)30925-9
- Makuvire TT, Latif Z, Kumar P, Samad Z, Warraich HJ. Trends in ischemic heart disease among females in low-and middle-income countries from 1990 to 2019. Int J Cardiol. 2023;388:
131113 . DOI: 10.1016/j.ijcard.2023.06.004 - Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–952. DOI: 10.1016/S0140-6736(04)17018-9
- Beza L, Leslie SL, Alemayehu B, Gary R. Acute coronary syndrome treatment delay in low to middle-income countries: a systematic review. Int J Cardiol Heart Vasc. 2021;35:
100823 . DOI: 10.1016/j.ijcha.2021.100823 - Rossello X, Gonzalez-Del-Hoyo M, Aktaa S, Gale CP, Barbash I, Claeys MJ, et al. European Society of Cardiology quality indicators for the management of acute coronary syndromes: developed in collaboration with the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the ESC. Eur Heart J Acute Cardiovasc Care. 2025;14:145–154. DOI: 10.1093/ehjacc/zuaf014
- Kibirige D, Atuhe D, Kampiire L, Kiggundu DS, Donggo P, Nabbaale J, et al. Access to medicines and diagnostic tests integral in the management of diabetes mellitus and cardiovascular diseases in Uganda: insights from the ACCODAD study. Int J Equity Health. 2017;16:
154 . DOI: 10.1186/s12939-017-0651-6 - Zhan L, Masoudi FA, Li X, Hu S, Venkatesh AK, Spertus JA, et al. Trends in cardiac biomarker testing in China for patients with acute myocardial infarction, 2001 to 2011: China PEACE-retrospective AMI study. PLoS One. 2015;10:
e0122237 . DOI: 10.1371/journal.pone.0122237 - Mehta S, Granger C, Grines CL, Jacobs A, Henry TD, Rokos I, et al. Confronting system barriers for ST- elevation MI in low and middle income countries with a focus on India. Indian Heart J. 2018;70:185–190. DOI: 10.1016/j.ihj.2017.06.020
- Turk-Adawi K, Sarrafzadegan N, Fadhil I, Taubert K, Sadeghi M, Wenger NK, et al. Cardiovascular disease in the Eastern Mediterranean region: epidemiology and risk factor burden. Nat Rev Cardiol. 2018;15:106–119. DOI: 10.1038/nrcardio.2017.138
- Bueno H, Rossello X, Pocock S, Van de Werf F, Chin CT, Danchin N, et al. Regional variations in hospital management and post-discharge mortality in patients with non-ST-segment elevation acute coronary syndrome. Clin Res Cardiol. 2018;107:836–844. DOI: 10.1007/s00392-018-1254-y
- Rossello X, Huo Y, Pocock S, Van de Werf F, Chin CT, Danchin N, et al. Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality. Int J Cardiol. 2017;245:27–34. DOI: 10.1016/j.ijcard.2017.07.039
- Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet. 2008;371:1435–1442. DOI: 10.1016/S0140-6736(08)60623-6
- Mendis S, Thygesen K, Kuulasmaa K, Giampaoli S, Mahonen M, Ngu Blackett K, et al. World Health Organization definition of myocardial infarction: 2008-09 revision. Int J Epidemiol. 2011;40:139–146. DOI: 10.1093/ije/dyq165
- Carson JL, Brooks MM, Hebert PC, Goodman SG, Bertolet M, Glynn SA, et al. Restrictive or liberal transfusion strategy in myocardial infarction and anemia. N Engl J Med. 2023;389:2446–2456. DOI: 10.1056/NEJMoa2307983
- Chapman AR, Anand A, Boeddinghaus J, Ferry AV, Sandeman D, Adamson PD, et al. Comparison of the efficacy and safety of early rule-out pathways for acute myocardial infarction. Circulation. 2017;135:1586–1596. DOI: 10.1161/CIRCULATIONAHA.116.025021
- Fearon WF, Zimmermann FM, De Bruyne B, Piroth Z, van Straten AHM, Szekely L, et al. Fractional flow reserve-guided PCI as compared with coronary bypass surgery. N Engl J Med. 2022;386:128–1237. DOI: 10.1056/NEJMoa2112299
- Kunadian V, Mossop H, Shields C, Bardgett M, Watts P, Teare MD, et al. Invasive treatment strategy for older patients with myocardial infarction. N Engl J Med. 2024;391:1673–1684. DOI: 10.1056/NEJMoa2407791
- Mueller C, Giannitsis E, Christ M, Ordonez-Llanos J, deFilippi C, McCord J, et al. Multicenter evaluation of a 0-hour/1-hour algorithm in the diagnosis of myocardial infarction with high-sensitivity cardiac troponin T. Ann Emerg Med. 2016;68:76–87.e4. DOI: 10.1016/j.annemergmed.2015.11.013
- Spitzer E, McFadden E, Vranckx P, Garcia-Garcia HM, Seltzer JH, Held C, et al. Critical appraisal of contemporary clinical endpoint definitions in coronary intervention trials: a guidance document. JACC Cardiovasc Interv. 2019;12:805–819. DOI: 10.1016/j.jcin.2018.12.031
- Stone GW, Sabik JF, Serruys PW, Simonton CA, Genereux P, Puskas J, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med. 2016;375:2223–2235. DOI: 10.1056/NEJMoa1610227
- Al-Zaiti SS, Martin-Gill C, Zegre-Hemsey JK, Bouzid Z, Faramand Z, Alrawashdeh MO, et al. Machine learning for ECG diagnosis and risk stratification of occlusion myocardial infarction. Nat Med. 2023;29:1804–1813. DOI: 10.1038/s41591-023-02396-3
- Cho KH, Ji YH, Joo S, Chang M, Oh S, Lim Y, et al. Novel artificial intelligence model using electrocardiogram for detecting acute myocardial infarction needing revascularization. Eur Heart J Digit Health. 2025;6:608–618. DOI: 10.1093/ehjdh/ztaf049
- Elias P, Jain SS, Poterucha T, Randazzo M, Lopez Jimenez F, Khera R, et al. Artificial intelligence for cardiovascular care—Part 1: Advances: JACC review topic of the week. J Am Coll Cardiol. 2024;83:2472–2486. DOI: 10.1016/j.jacc.2024.03.400
- Alizadehsani R, Khosravi A, Roshanzamir M, Abdar M, Sarrafzadegan N, Shafie D, et al. Coronary artery disease detection using artificial intelligence techniques: a survey of trends, geographical differences and diagnostic features 1991–2020. Comput Biol Med. 2021;128:
104095 . DOI: 10.1016/j.compbiomed.2020.104095 - Dang QM, Psaltis PJ, Burgess S, Chandrasekhar J, Mukherjee S, Kritharides L, et al. The Australian-New Zealand spontaneous coronary artery dissection cohort study: predictors of major adverse cardiovascular events and recurrence. Eur Heart J. 2025;46:2012–2023. DOI: 10.1093/eurheartj/ehaf097
- DeFilippis AP, Abbott JD, Herbert BM, Bertolet MH, Chaitman BR, White HD, et al. Restrictive versus liberal transfusion in patients with type 1 or type 2 myocardial infarction: a prespecified analysis of the MINT trial. Circulation. 2024;150:1826–1836. DOI: 10.1161/CIRCULATIONAHA.124.071208
- Chaitman BR, Alexander KP, Cyr DD, Berger JS, Reynolds HR, Bangalore S, et al. Myocardial infarction in the ISCHEMIA trial: impact of different definitions on incidence, prognosis, and treatment comparisons. Circulation. 2021;143:790–804. DOI: 10.1161/CIRCULATIONAHA.120.047987
- Gregson J, Stone GW, Ben-Yehuda O, Redfors B, Kandzari DE, Morice MC, et al. Implications of alternative definitions of peri-procedural myocardial infarction after coronary revascularization. J Am Coll Cardiol. 2020;76:1609–1621. DOI: 10.1016/j.jacc.2020.08.016
DOI: https://doi.org/10.5334/gh.1578 | Journal eISSN: 2211-8179
Language: English
Page range: 64 - 64
Submitted on: Jul 31, 2026
Accepted on: Jul 31, 2026
Published on: Aug 28, 2026
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Keywords:
© 2026 Nicholas L. Mills, L. Kristin Newby, Sarah Zaman, Wael A. Almahmeed, Chiara Bucciarelli-Ducci, Monica M. Colvin, George D. Dangas, Holli A. DeVon, Rohan Dharmakumar, Thomas A. Gaziano, Derek J. Hausenloy, Mohamed Jeilan, Konstantinos C. Koskinas, Bertil Lindahl, Zuzana Motovska, Maria Rubini Gimenez, Ana María Salvati, Jacqueline E. Tamis-Holland, ESC/ACC/AHA/WHF Universal Definition Document Advisory Group, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.